ReleaseWire - Latest Press Releases

Fact.MR has announced the addition of the “Electronystagmography Testing Market Forecast, Trend Analysis & Competition Tracking - Global Market Insights 2018 to 2028"report to their offering.

Rockville, MD -- (SBWIRE) -- 12/26/2018 -- Electronystagmography testing is a diagnostic test used to record spontaneous eye activities. Electronystagmography testing can be used to identify the cause of dizziness, balance dysfunction, and vertigo by testing the vestibular system. Electronystagmography testing is used to detect even the slightest movement of the eyes. The electronystagmography testing is done by using disc electrodes which are attached around the nose and electrical leads of discs electrode are connected to an oscilloscope to measure the spontaneous eye movement. In electronystagmography testing, the movement of the eye is accurately recorded because the cornea is electropositive and retina is electronegative due to which these electrodes accurately record the spontaneous movement of the eye. Basically, electronystagmography testing consists of series of diagnostic tests including Videonystagmography, Rotary Chair Test, Computerized Dynamic Visual Acuity (DVA), Computerized Dynamic Posturography (CDP), Subjective Visual Vertical, and Vestibular Evoked Myogenic Potential (VEMP). Videonystagmography test (VNG test) records the eye movement in a dark, as well as light room with the help of a video camera, mounted inside the goggles that are worn during testing.

Get Free Exclusive Sample Copy of This Report @ https://www.factmr.com/connectus/sample?flag=S&rep_id=2273

Videonystagmography test in electronystagmography testing is performed to evaluate eye movements. Calibration test evaluates spontaneous eye movement. The positional test evaluates head position changes and calorie test evaluates eye response to cool air or water and warm air or water placed in the ear canal. They are the parts of Videonystagmography test. The rotary chair test in electronystagmography testing is used to determine whether the symptoms are because of inner ear disorder or brain disorder. Computerized Dynamic Visual Acuity (DVA) testing in electronystagmography testing is used to determine how vestibular problem affects vision during activities like walking, riding, or turning head from one side to another. Computerized Dynamic Posturography (CDP) testing in electronystagmography testing is used to evaluate how well patients responds during balance. Subjective Visual Vertical testing in electronystagmography testing is done to evaluate the sensing gravity of utricle (ear organ). Vestibular Evoked Myogenic Potential (VEMP) testing in electronystagmography testing is done to evaluate the working of saccule (ear organ) and vestibular nerve.

Electronystagmography Testing Market: Drivers and Restraints

The increasing number of inner ear disorders that cause vertigo is likely to boost the demand for electronystagmography testing market. Also, increasing healthcare spending, better infrastructure, and reimbursement facilities are expected to be the major factors driving the growth of the electronystagmography testing market over the forecast period. However, limited awareness about related disorders in the developing nations, the high cost of the tests & devices, and availability of cheap alternatives in the market are expected to be the major restraining factors for the growth of the electronystagmography testing market.

Electronystagmography Testing Market: Segmentation

Tentatively, the global electronystagmography testing market can be segmented on the basis of test type, indication, end user, and geography.

Based on the test type, the global electronystagmography testing market is segmented into:

Videonystagmography
Rotary Chair Test
Computerized Dynamic Visual Acuity (DVA)
Computerized Dynamic Posturography (CDP)
Subjective Visual Vertical
Vestibular Evoked Myogenic Potential (VEMP)
Based on the indication, the global electronystagmography testing market is segmented into:

Vertigo
Dizziness
Balance Dysfunction
Involuntary Eye Movement (Nystagmus)
Others
Based on the end user, the global electronystagmography testing market is segmented into:

Hospitals
Clinics
Diagnostic Centers
Others

Request Brochure of this Report @ https://www.factmr.com/connectus/sample?flag=B&rep_id=2273
Electronystagmography Testing Market: Overview

The global market for electronystagmography testing is expected to witness high growth over the forecast period. Based on test type, the global electronystagmography testing system market is segmented into Videonystagmography, Rotary Chair Test, Computerized Dynamic Visual Acuity (DVA), Computerized Dynamic Posturography (CDP), Subjective Visual Vertical, and Vestibular Evoked Myogenic Potential (VEMP). Based on indications, the global electronystagmography testing system market is segmented into vertigo, dizziness, balance dysfunction, and involuntary eye movement (Nystagmus). Based on the end user, the market is segmented into hospitals, clinics, diagnostic centers, and others. Electronystagmography testing requires skilled professionals to perform the test. Due to the presence of good physicians and comparatively better availability of skilled professionals, hospitals are preferred for testing compared to clinics and diagnostic centers.

Electronystagmography Testing Market: Regional Outlook

Geographically, the global electronystagmography testing market is segmented into North America, Latin America, Europe, Asia-Pacific excluding Japan (APEJ), Japan, and the Middle East & Africa (MEA). North America is expected to be dominant in the global electronystagmography testing market owing to lifestyle changes, new product innovations, early treatment adoption, and high health care spending as compared to other regions. Europe is expected to register the second largest share in the global electronystagmography testing market due to development activities, owing to increased awareness and large research base. The electronystagmography testing market in the Asia Pacific excluding Japan is expected to grow at a significant CAGR due to the expansion of product offerings by the key domestic players.

Electronystagmography Testing Market: Key Players

The global electronystagmography testing market is highly fragmented owing to the presence of a large number of domestic manufacturers. Examples of some of the key players operating in the global electronystagmography testing market are DIFRA Instrumentation, Interacoustics, Micromedical Technologies, Neurocom International, Neuro Kinetics, Otometrics, SensoMotoric Instruments, Balanceback, BeOn Solutions, BioMed Jena, Recorders & Medicare Systems, Happersberger Otopront GmbH, Interacoustics, and others.

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts, and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

The report covers exhaustive analysis on:

Market Segments
Market Dynamics
Market Size
Supply & Demand
Current Trends/Issues/Challenges
Competition & Companies Involved
Technology
Value Chain
Regional analysis includes:

North America (U.S., Canada)
Latin America (Mexico, Brazil)
Western Europe (Germany, Italy, U.K, Spain, France, Nordic countries, BENELUX)
Eastern Europe (Russia, Poland, Rest Of Eastern Europe)
Asia Pacific Excluding Japan (China, India, Australia & New Zealand)
Japan
Middle East and Africa (GCC, S. Africa, Rest Of MEA)
Report Highlights:

Detailed overview of the parent market
Changing market dynamics in the industry
In-depth market segmentation
Historical, current, and projected market size in terms of volume and value
Recent industry trends and developments
Competitive landscape
Strategies of key players and products offered
Potential and niche segments, geographical regions exhibiting promising growth
A neutral perspective on market performance
Must-have information for market players to sustain and enhance their market footprint.

For more information on this report, please visit:https://www.factmr.com/report/2273/electronystagmography-testing-market

About Fact.MR
Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.

For more information on this press release visit: http://www.sbwire.com/press-releases/electronystagmography-testing-market-forecast-and-segments-2018-to-2028-1111271.htm

Media Relations Contact

Sudip Shaha
Head of Marketing
Fact.MR
Telephone: 353-1-6111-593
Email: Click to Email Sudip Shaha
Web: https://www.factmr.com

HealthyTOKYO opens the first vegan cafe in Haneda Airport Terminal 2. Local demand for delicious plant-based food and drink increases along with the growing wave of tourists to Japan.

Tokyo, Japan -- (ReleaseWire) -- 12/26/2018 -- Good news for those looking for a vegan restaraunt in Haneda Airport (also known as Tokyo International Airport). The HealthyTOKYO Cafe & Shop opens its doors to the public on December 28, 2018. The first all-vegan cafe here serves an array of delicious wholesome and healthy plant-based dishes in the fourth most traveled airport in the world.

Among the offerings you will find carefully prepared quiche, lasagna, salads and sandwiches. All of the flour and rice is certified organic. Don't miss the wonderful vegan breads and desserts including the groundbreaking all-natural "melon pan" in five flavors, N.Y style cheesecake and an array of other scrumptious treats. Gluten-free options are also available.

The Cafe serves organic coffee, lattes, matcha drinks, homemade ginger ale and lemonade as well as a great selection of high quality natural teas. Several Japanese craft beers are available on tap, complimented with a nice grouping of canned craft beers from the USA.

The HealthyTOKYO Cafe & Shop carries unique gifts and snacks to take on your flight. You will find HealthyTOKYO original Amazake Matcha Latte Mix, pure nut butters (don't miss the pistachio!) and the highest quality organic matcha available in the land that created this green superfood. On the shelves you will also find a substantial selection of CBD oils and products.

"We really wanted to make a cafe that everyone can enjoy", says David Israelsson, Head of Operations at HealthyTOKYO K.K. "While all of our offerings are plant-based, we have created dishes that will be loved by vegans and omnivores alike. Our menus are designed to appeal to the tastes of locals and the increasing number of visitors to Japan", he added.

This is the first brick and mortar offering from HeathyTOKYO K.K. The company has a well-established online presence providing practical advice about staying healthy in Japan and an online shop for additive-free, organic and other food offerings. Their initial focus was on the English-speaking audience living or visiting in Japan and is now expanding to the local Japanese population.

Japan is experiencing a tourism boom with the number of travelers expected to reach about 30 million in 2018, up from 10.4 million in 2013. With the Olympics to be held in Tokyo in 2020, the upward trend is forecasted to continue well into the future. With this influx of visitors, the demand for vegan fare is also on the rise.

Worldwide growth of plant-based food consumption is increasing dramatically as people come to realize the health benefits of more vegetables, grains and fruits in their diets. In Australia, about 10% of the population is now meat-free and in the USA the number of people identifying as Vegan has risen from 1% in 2014 to 6% in 2017. For many others it is not necessarily about eliminating animal products from the diet, it's more about reducing and replacing them with plant-based alternatives.

In Japan, about 5% of the population is vegetarian and close to 3% identify as Vegan. There is certainly a growing consciousness in this country as in others, but fewer places that cater to vegetable lovers.

The number of vegan restaurants in Tokyo is sure to increase and the HealthyTOKYO Cafe & Shop is an outstanding and welcome first vegan addition in Haneda Airport Terminal 2.

Hours: Open 365 days a year 6:30-20:00
Address: Haneda Airport Terminal 2 (3F)
Phone: +81(03)-4405-6502
Website: https://healthytokyo.com

For more information on this press release visit: http://www.releasewire.com/press-releases/first-vegan-restaurant-in-haneda-airport-opens-its-doors-to-rising-demand-1111420.htm

Media Relations Contact

David Israelsson
Head of Operations
HealthyTOKYO K.K.
Telephone: 03-4405-6201
Email: Click to Email David Israelsson
Web: https://healthytokyo.com

Fact.MR has announced the addition of the “Neuralgia Treatment Market Forecast, Trend Analysis & Competition Tracking - Global Market Insights 2018 to 2028"report to their offering.

Rockville, MD -- (SBWIRE) -- 12/26/2018 -- Neuralgia is an abnormal symptom with effects like sharp, burning, and mostly severe pain, due to an irritated or damaged nerve. The causative nerve may be from anywhere in the body, The damage caused by the nerve is associated with several factors like aging, cardiovascular diseases, diabetes, multiple sclerosis, shingles infection, and more. Therefore, Neuralgia Treatment for the pain is directed towards its roots or its site of origin. Potential Neuralgia Treatment may include surgery to relieve the pressure, control of sugar level in the blood of diabetic patients, physical therapy or body massage, epidural injections to 'turn off' pain signals and reduce inflammation directed at a particular nerve or nerve group, and medicinal Neuralgia Treatment to reduce the pain. The Neuralgia Treatment market is driven by the occurrence of common neuralgias such as trigeminal, postherpetic, glossopharyngeal, and occipital neuralgia. More uncommon Neuralgia Treatment may be required for periorbital and auricular neuralgias.

Neuralgia Treatment Market: Drivers and Restraints

The global Neuralgia Treatment market is primarily driven by the increase in the geriatric population around the world. The disorder is more common in people aged 50 years or more, which drives the Neuralgia Treatment market. Although, it can occur at any age. Adults suffering from multiple sclerosis and diabetes also have a high risk of developing neuralgias, which also significantly contributes to the Neuralgia Treatment market. According to the National Institute of Neurological Disorders and Strokes (NINDS) 2018 report, the incidences of new cases is approximately 12 per 100,000 people per year. The disorder is more common in women than in men. If pain still persists even after conservative Neuralgia Treatment for several months, it is recommended to undergo spine surgery. Neuralgia Treatment involving spine surgery comes with high medical costs, and is unaffordable for people from low income regions such as Asia and Africa, where most people often remain untreated.

Get Free Exclusive Sample Copy of This Report @ https://www.factmr.com/connectus/sample?flag=S&rep_id=2282

Overall, drug-based Neuralgia Treatment therapy will remain the first line of treatment for many, and will contribute majorly to the global Neuralgia Treatment market. However, nerve blocks surgery and other procedures may be necessity in a few cases as far as Neuralgia Treatment is concerned.

Neuralgias Market: Segmentation

Tentatively, the global Neuralgia Treatment market can be segmented on the basis of treatment type, distribution channel, and geography.

Based on treatment type, the global Neuralgia Treatment market is segmented as:

Medications for Neuralgia Treatment
Anticonvulsant Medicines
Carbamazepine
Oxcarbazepine
Topiramate
Gabapentin
Pregabalin
Clonazepam
Phenytoin
Lamotrigine
Valproic acid
Tricyclic Antidepressants
Amitriptyline
Nortriptyline
Surgeries for Neuralgia Treatment
Balloon Compression
Glycerol Injection
Radiofrequency Thermal Lesioning
Stereotactic Radiosurgery
Microvascular Decompression
Complementary Approaches for Neuralgia Treatment (in combination with medications)
Based on distribution channel, the global Neuralgia Treatment market is segmented as:

Hospital Pharmacies
Retail Pharmacies
Drug Stores
Online Pharmacies
Others
Neuralgia Treatment Market: Overview

Overall incidence estimates for various neuralgias conditions are as follows: 4.3/100,000/year for Trigeminal Neuralgia, 3.3/100,000/year for Postherpetic Neuralgia, 0.7/100,000/year for Glossopharyngeal Neuralgia, and 3.2/100,000/year for Occipital Neuralgia. Based on such indices, the Neuralgia Treatment market is poised to grow at a significant rate. In the Neuralgia Treatment market, pharmacologic agents will remain as the primary line of treatment for many. The most common neuralgias that drive the Neuralgia Treatment market include trigeminal, postherpetic, glossopharyngeal, and occipital neuralgia. These neuralgias differ in their pathophysiology, topography, complications, and treatment approach, necessitating awareness amongst individuals.

Request Brochure of this Report @ https://www.factmr.com/connectus/sample?flag=B&rep_id=2282

Neuralgia Treatment Market: Regional Outlook

Globally, North America, which includes the U.S., is expected to majorly contribute to the Neuralgia Treatment market. Aggressive healthcare investments and increasing awareness among people about Neuralgia Treatments will contribute to the growth of this region's market. Asia Pacific is anticipated to have the second-largest market share in the Neuralgia Treatment market, primarily due to the largest geriatric population in the world present in China, India, and Japan. In addition, improved living conditions and better health care initiatives by governing bodies will also fuel the growth of the Neuralgia Treatment market. Europe, with its rising prevalence of chronic pain disorders in its developed and developing countries, will be the third-largest contributor to the Neuralgia Treatment market. Latin America and the Middle East & Africa are expected to show considerable growth in the neuralgias market in the near future, thanks to some of the developed and emerging economies such as GCC countries, Brazil, and Mexico, which are evolving with good healthcare governance.

Neuralgia Treatment Market: Key Players

Some of the key players operating in the global neuralgias market are Allergan Plc, Merz Pharma GmbH & Co., Biogen, Inc., Merz Pharma GmbH & Co., Abbott Laboratories, Trigemina Inc., Pfizer Inc., Novartis, GlaxoSmithKline Plc. F, Lupin, and others.

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, and inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators, and governing factors, along with market attractiveness as per segment. The report also maps the qualitative impact of various market factors on market segments and geographies.

The report covers exhaustive analysis on:

Market Segments
Market Dynamics
Market Size
Supply & Demand
Current Trends/Issues/Challenges
Competition & Companies Involved
Technology
Value Chain
Regional analysis includes:

North America (U.S., Canada)
Latin America (Mexico, Brazil, Argentina, Peru, Chile, Rest of LATAM)
Europe (Germany, Italy, U.K, Spain, France, Nordic countries, BENELUX, Eastern Europe, Rest of Europe)
CIS & Russia
Japan
Asia Pacific Excluding Japan ( Greater China, India, South Korea, ASEAN Countries, Rest of APEJ)
Middle East and Africa (GCC Countries, Turkey, Iran, Israel, S. Africa, Rest of MEA)
Report Highlights:

Detailed overview of parent market
Changing market dynamics in the industry
In-depth market segmentation
Historical, current and projected market size in terms of volume and value
Recent industry trends and developments
Competitive landscape
Strategies of key players and products offered
Potential and niche segments, geographical regions exhibiting promising growth
A neutral perspective on market performance
Must-have information for market players to sustain and enhance their market footprint

For more information on this report, please visit:https://www.factmr.com/report/2282/neuralgia-treatment-market

About Fact.MR

Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.

For more information on this press release visit: http://www.sbwire.com/press-releases/neuralgia-treatment-market-revenue-and-value-chain-2018-to-2028-1111272.htm

Media Relations Contact

Sudip Shaha
Head of Marketing
Fact.MR
Telephone: 353-1-6111-593
Email: Click to Email Sudip Shaha
Web: https://www.factmr.com

Fact.MR has announced the addition of the “Mammography Detectors Market Forecast, Trend Analysis & Competition Tracking - Global Market Insights 2018 to 2028"report to their offering.

Rockville, MD -- (SBWIRE) -- 12/26/2018 -- Mammography detector is a tool used to detect and diagnose breast cancer by taking X-ray of the breast. The mammography image by mammography detectors is become the key element for the diagnosis of breast cancer. Mammography detectors pass low dose x-ray to detect cancer early – before women experience symptoms. There are various types of mammography detectors available in the market, viz. computer radiography detector, flat panel detector, CMOS flat panel detector. Computer radiography detector is the most widely user mammography detector. However, this mammography detector has certain limitation due to storage screens with optical readout in a dedicated scanner. Flat panel detector provides better resolution than computer radiography detector owing to use of specialized TFT panels made of amorphous silicon for diagnosis of cancer. CMOS flat detector is the latest type of mammography detector available in the market. This type of mammography detector has several advantages than the previous version such as lower noise and power consumption, and much higher resolution and speed. This type of mammography detectors have increased the patient comfort and also significantly increased the quality of medical care.

Mammography Detectors Market: Drivers and Restraints

Rising incidences of breast cancer throughout the globe is the primary factor driving the growth of the mammography detectors market. For instance, menopausal hormone therapy increases the risk of breast cancer. Additionally, rising geriatric population and increase in cases of hormonal imbalance will propel the growth of the mammography detectors market. Moreover, rising awareness among the people about breast cancer after launching various awareness program by NGO's in different geographies is also expected to upsurge the growth of the mammography detectors market. On other hand, discomfort to the patients, and side effects associated with mammography may limit the growth of the mammography detectors market over the forecast period. The high consultation fees taken by diagnostic center for mammography test may also deter the growth of mammography detectors market.

Get Free Exclusive Sample Copy of This Report @ https://www.factmr.com/connectus/sample?flag=S&rep_id=2275

Mammography Detectors Market: Segmentation

Tentatively, the global mammography detectors market can be segmented on the basis of detector type, end user and geography.

Based on detector type, the global mammography detectors market is segmented as:

Computed Radiography Detectors
Flat Panel Detectors
CMOS Flat Detectors
Based on end user, the global mammography detectors market is segmented as:

Hospitals
Diagnostic Centers
Mammography Detectors Market: Overview

The mammography detectors market is expected to show exponential growth over the forecast period owing rising incidences of breast cancer among the women throughout the globe. According to National Cancer Institute, there are about 2,300 new cases of breast cancer in men each year, and about 230,000 new cases in women each year. According to few of the expert every women should take mammography test once in year which will rise the demand of mammography detectors in the global market. By detector type, computed radiography detectors is expected to be the most dominant segment due to its wide acceptance this type of mammography detector among the hospitals and diagnostic centers. CMOS flat detector segment by detector type in global mammography detectors market is the projected to show higher growth due its advance feature. Among all the end user hospital segment will dominate mammography detectors market whereas diagnostic center is projected to show relatively high growth rate.

Request Brochure of this Report @ https://www.factmr.com/connectus/sample?flag=B&rep_id=2275

Mammography Detectors Market: Regional Outlook

Geographically, the global mammography detectors market is segmented into North America, Latin America, Europe, CIS and Russia, Asia-Pacific excluding Japan (APEJ), Japan and the Middle East and Africa (MEA). North America is expected to gain maximum share for mammography detectors market in term of revenue owing to increased incidences of breast cancer. After North America mammography detectors market is followed by Europe and APEJ due to rising awareness among the people about the breast cancer. Asia-Pacific excluding Japan region is expected to grow at faster rate than other region for mammography detectors market due high geriatric population in India and China. Middle East and Africa is expected show delayed growth for mammography detectors due to lack awareness among the people and low healthcare spending.

Mammography Detectors Market: Key Players

Examples of some of the key players operating in the global mammography detectors market are Analogic Corporation, Sigmascreening, GE Healthcare, Hologic, Inc, Koninklijke Philips N.V., Hologic, Inc, Gamma Medical, Inc., Siemens Healthcare, SonoCine, Inc, and Toshiba Corporation.

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

The report covers exhaustive analysis on:

Market Segments
Market Dynamics
Market Size
Supply & Demand
Current Trends/Issues/Challenges
Competition & Companies involved
Technology
Value Chain
Regional analysis includes

North America (U.S., Canada)
Latin America (Mexico, Brazil)
Europe (Germany, Italy, U.K, Spain, France, Nordic)
CIS and Russia
Asia Pacific Excluding Japan (China, India, Australia & New Zealand)
Japan
Middle East and Africa (GCC, S. Africa, Rest Of MEA)
Report Highlights:

For more information on this report, please visit:https://www.factmr.com/report/2275/mammography-detectors-market

About Fact.MR

For more information on this press release visit: http://www.sbwire.com/press-releases/mammography-detectors-market-to-register-a-healthy-cagr-for-the-forecast-period-2018-to-2028-1111273.htm

Media Relations Contact

Sudip Shaha
Head of Marketing
Fact.MR
Telephone: 353-1-6111-593
Email: Click to Email Sudip Shaha
Web: https://www.factmr.com

Fact.MR has announced the addition of the “Actigraphy Sensors Market Forecast, Trend Analysis & Competition Tracking - Global Market Insights 2018 to 2028"report to their offering.

Rockville, MD -- (SBWIRE) -- 12/26/2018 -- Actigraphy sensors are the devices used to evaluate physical movements of an individual with sleep disorders. Actigraphy sensors collect information by monitoring body movements during sleep. Actigraphy sensors is the small portable device that collects resulting information by tracking physical motion. Actigraphy sensor is a device which is commonly worn on the wrist, ankle, or neck of the body. The device has been developed based on the assumption that when an individual sleeps, his/her body activity reduces and that activity can be used as an indicator for identifying sleep disorders. Many research studies have been going on to identify the reason for sleep disorders by evaluating the idle activity cycles of a patient. Actigraphy sensors provides more accurate data than self-reported sleep durations. Actigraphy sensors are becoming very popular among patients with sleep disorders. Manufacturers introducing novel actigraphy sensors in the market such as actigraphy watch which has accelerometer sensor that tracks real-life activities done at home. Data collected with actigraphy watch recognize wake-sleep cycles of patients which can be seen in the computer one or two week later after analysis. The data collected can help the doctor to treat the patients and detect the actual reason for the disorders. This advantage of actigraphy sensors can attribute to the growth of the global actigraphy sensors market.

Get Free Exclusive Sample Copy of This Report @ https://www.factmr.com/connectus/sample?flag=S&rep_id=2274

According to the National Center for Biotechnology Information and U.S. National Library of Medicine, in general population, diagnosis of insomnia is only about 6%-15%. Approximately 2-4% of the population suffers from the sleep apnea syndrome. The restless legs syndrome is seen in approximately 6% of the population, with a high prevalence in geriatric population. Narcolepsy has a prevalence of 0.04% and nocturnal terrors, a prevalence of 2.2%-5%. However, most sleep disorders remain unidentified. Less than 20% of individuals are properly diagnosed and treated for sleep disorders. Extensive studies are carried out on sleep paralysis which affects approximately 6% of the general population. Among all these, parasomnias are studied less, as its prevalence remains unknown. The International Classification of Sleep Disorders listed more than 80 different types of sleep disorder diagnoses. The growing prevalence of sleep disorders are the key factors for new innovations and development of the actigraphy sensors market. However, less awareness about different types of sleep disorders and negligence of symptoms can affect the growth of the actigraphy sensors market.

Actigraphy Sensors Market: Drivers and Restraints

The growing prevalence of sleep disorders is the major driving factor in the growth of the actigraphy sensors market over the forecast period. The prevalence of sleep disorders was significantly higher in different shift working population which mostly remain undiagnosed. Innovations and adaptation of new technology are the other important factors contributing to the growth of the global actigraphy sensors market. However, limited awareness about different types of sleep disorders, poor lifestyle, and negligence of early symptoms is restraining the revenue growth in the global actigraphy sensors market.

Request Brochure of this Report @ https://www.factmr.com/connectus/sample?flag=B&rep_id=2274

Actigraphy Sensors Market: Segmentation

The global actigraphy sensors market can be segmented on the basis of product type, indication, application, and geography.

Based on product type, the global actigraphy sensors market is segmented into:

Watch
Fitbit
Based on indication, the global actigraphy sensors market is segmented into:

Sleep Apnea
Insomnia
Narcolepsy
Restless Leg Syndrome
Rapid Eye Movement Behavior Disorder
Delayed Sleep Phase Syndrome
Sleepwalking
Based on application, the global actigraphy sensors market is segmented into:

Sleep Medicine
Sleep Disorder
Circadian Rhythm Disorder
Daytime Activity Research
Actigraphy Sensors Market: Overview

The global market for actigraphy sensors is expected to witness high growth over the forecast period. Increasing prevalence of sleeping disorders is observed in working population with unusual timings. Innovations and adaptation of new technology are the other important factors contributing to the growth of the global actigraphy sensors market.

Actigraphy Sensors Market: Regional Outlook

Geographically, the actigraphy sensors market is segmented into North America, Latin America, Europe, Asia-Pacific excluding Japan (APEJ), Japan, and the Middle East & Africa (MEA). North America's actigraphy sensors market is expected to dominate the global market followed by Europe, due to significant improvement in health awareness, assessment, and expenditure along with rapidly growing economy. However, the Asia Pacific actigraphy sensors market is also estimated to grow at a high rate over the forecast period due to expansion of healthcare structure and increase in number of patient population.

Actigraphy Sensors Market: Key Players

Examples of some of the key players operating in the global actigraphy sensors market are Philips Respironics, Aetna, Activinsights, and others.

The report covers exhaustive analysis on:

Market Segments
Market Dynamics
Market Size
Supply & Demand
Current Trends/Issues/Challenges
Competition & Companies involved
Technology
Value Chain
Regional analysis includes

For more information on this report, please visit:https://www.factmr.com/report/2274/actigraphy-sensors-market

For more information on this press release visit: http://www.sbwire.com/press-releases/actigraphy-sensors-market-forecasts-and-growth-2018-to-2028-1111274.htm

Media Relations Contact

Sudip Shaha
Head of Marketing
Fact.MR
Telephone: 353-1-6111-593
Email: Click to Email Sudip Shaha
Web: https://www.factmr.com

Fact.MR has announced the addition of the “Dental Amalgamators Market Forecast, Trend Analysis & Competition Tracking - Global Market Insights 2018 to 2028"report to their offering.

Rockville, MD -- (SBWIRE) -- 12/26/2018 -- Dental issues such as toothaches, stained teeth, chipped tooth, sensitivity, hyperdontia, and cavities are common in the today's world. The treatment for teeth requires serious attention. Progression in dentistry has led to the invention of the dental amalgamator, which is a specially designed machine to triturate or amalgamate an alloy and mercury. Dental amalgamators are used to make amalgam or fillings. Dental amalgamator helps to triturate or amalgate the alloy and mercury due to which it is in critical demand in market. The usability of dental amalgamators in dental clinics and hospitals helps to reduce the labor stress thereby increasing the work efficiency of the practitioners. In order to upgrade the clinic and workplace of a dentist, specialized dental amalgamators are broadly used in the clinics. Dentist job can be optimized by using high-quality, cost-effective dental amalgamators amongst all the dental equipment as they provide a fast and formed mix of dental amalgam when compared to traditional hand trituration techniques. The dental amalgamators were founded in 1896 by Dr. G.V. Black. Updated dental amalgamators are readily available online by the dental equipment companies, and they are mostly favoured by the dental professionals in dental clinics and hospitals. Dental amalgamator has the ability of self-sealing which helps to enhance the restoration integrity. It also helps to reduce the chances of micro leakage. These are the factors due to which it is in demand across clinics. Dental amalgamators also have a cradle for holding amalgam capsules containing its cover. They function at different speeds to ensure proper mix of different types of alloy compositions.

Dental Amalgamators Market: Drivers and Restraints

As the prevalence of dental diseases are increasing in developed regions so dental amalgamators attracts more from end users side. This is because of having advance technology. It leads to increase the strong competition among domestic players. The advantages of upgraded dental amalgamators such as they are stronger than the ceramic or resin fillings and they are more durable are expected to increase the demand for dental amalgamators. Dental amalgamators are equipped with latest monitor system and equipment to perform cavity filling and minor surgeries, that would further generate high demands for the Dental Amalgamators. The growing demand for Dental Amalgamators indicated for ease of the cavity filling procedure by offering easy accessibility to tools for the dentists is expected to be the major factor driving the growth of the Dental Amalgamators market over the forecast period. Dental amalgamators are available in a single speed version, or multiple speeds.

Get Free Exclusive Sample Copy of This Report @ https://www.factmr.com/connectus/sample?flag=S&rep_id=2276

Dental Amalgamators Market: Segmentation

Tentatively, the dental amalgamators market can be segmented on the basis of product type and end user.

On the basis of product type, the dental amalgamators market is segmented into:

Simple Dental Amalgamators
Multi-functional Dental Amalgamators
Others
On the basis of end users, the dental amalgamators market is segmented into:

Dental Clinics
Dental Laboratories
Physician Practice
Hospitals
Others
Dental Amalgamators Market: Overview

The global market for Dental Amalgamators is expected to grow over the forecast period by introducing multi-functional Dental Amalgamators having features like different speeds with the help of which one can set the speed according to the need. Dental amalgamators have speed levels of slow, medium and fast, with variable frequency levels. Investments to introduce products in the Dental Amalgamators market to capitalize on the opportunities in the untapped market is also expected to raise the revenue generation in Dental Amalgamators market. Different types of Dental Amalgamators are being introduced in the Dental Amalgamators market recently by leading players such as Gnatus, Best Dent Equipment Co. Ltd., BMS dental, GC Europe, Ivoclar Vivadent Kerrhawe, KerrHawe SA, TAC, Carlo de Giorgi SRL, MHC TECHNOLOGY, Tenko Medical Systems, Motion Dental Equipment Corporation, Ivoclar Vivadent Kerrhawe, among others. Among the product type, the simple/multi-functional Dental Amalgamators segment is expected to lead the Dental Amalgamators market over the forecast period. Specialty clinics and hospitals is expected to take part in high revenue share in the Dental Amalgamators market on the account of high demand for Dental Amalgamators generated from Dental Amalgamators specialist clinics.

Request Brochure of this Report @ https://www.factmr.com/connectus/sample?flag=B&rep_id=2276

Dental Amalgamators Market: Regional Outlook

Geographically, the Dental Amalgamators market is segmented into viz. North America, Europe, Latin America, Asia-Pacific excluding Japan (APEJ), Japan and the Middle East and Africa (MEA). North America is assumed to generate the largest revenue share in the Dental Amalgamators market as they have the presence of large number of specialty clinics and advanced healthcare. However, Asia-Pacific is expected to have the fastest growth in revenue generation for Dental Amalgamators market as they local manufacturers in countries such as Japan, China and India whereas, Latin America have the presence of constricted plan is expected for Dental Amalgamators demand in the region.

Dental Amalgamators Market: Key Players

Some of the key players in the dental amalgamators market are Gnatus, Best Dent Equipment Co. Ltd., BMS dental, GC Europe, Ivoclar Vivadent Kerrhawe, KerrHawe SA, TAC, Carlo de Giorgi SRL, MHC TECHNOLOGY, Tenko Medical Systems, Motion Dental Equipment Corporation, Navadha Enterprises, Tenko Medical Systems, Three Stars Trade Sp Z.oo, TPC, Dentsply International, LINEA, and Ivoclar Vivadent Kerrhawe, among others.

The report covers exhaustive analysis on:

Market Segments
Market Dynamics
Market Size
Supply & Demand
Current Trends/Issues/Challenges
Competition & Companies involved
Technology
Value Chain
Regional analysis includes

North America (U.S., Canada)
Latin America (Mexico, Brazil, Argentina, Chile, Peru, and Rest of Latin America)
Europe [EU -4 (Germany, France, Italy, Spain), BENELUX (Belgium, Netherlands, Luxemburg), NORDIC (Norway, Denmark, Iceland, Sweden), Eastern Europe (Poland, Ukraine, Czech Rep. etc.), Rest of Europe
CIS & Russia
Japan
APEJ (Greater China, India, S. Korea, ASEAN Countries and Rest of APEJ)
Middle East & Africa (GCC Countries, Turkey, Iran, Israel, South Africa, Rest of MEA)
Report Highlights:

For more information on this report, please visit:https://www.factmr.com/report/2276/dental-amalgamators-market

About Fact.MR

For more information on this press release visit: http://www.sbwire.com/press-releases/dental-amalgamators-market-drivers-restraints-opportunities-and-threats-2018-to-2028-1111275.htm

Media Relations Contact

Sudip Shaha
Head of Marketing
Fact.MR
Telephone: 353-1-6111-593
Email: Click to Email Sudip Shaha
Web: https://www.factmr.com

Fact.MR has announced the addition of the “Hand Hygiene Monitoring System Market Forecast, Trend Analysis & Competition Tracking - Global Market Insights 2018 to 2028"report to their offering.

Rockville, MD -- (SBWIRE) -- 12/26/2018 -- Hand hygiene monitoring systems are used to record and maintain the hand hygiene of caretakers in hospitals and clinics. According to the BC Centre for Disease Control, 8% of infectious diseases are spread through unwashed hands. Our hands carry plethora of germs and micro-organisms responsible for infections and are the convenient way to pass it to another person who comes in contact. Individuals tend to ingest these disease causing micro-organisms in their systems without even realizing it. Hand hygiene is important to eliminate the risk of infections, which consequently reduces the cost of healthcare expenditure. Hand hygiene is particularly vital in healthcare facilities, clinics and hospitals. The WHO and many other organizations have issued guidelines and recommendations to improve hand hygiene on medical sites and advised to use hand hygiene monitoring systems.

Get Free Exclusive Sample Copy of This Report @ https://www.factmr.com/connectus/sample?flag=S&rep_id=2277

After numerous management efforts, hygiene monitoring systems are introduced, which sends notifications and alerts to the individual for washing the hands and maintaining the hygiene. Hand hygiene monitoring system can be a badge or wrist band worn by the healthcare worker with a sensor at the patient bed, which detects the level of hygiene. Some hand hygiene monitoring systems have sensors or biometrics attached to the soap and sanitizer dispenser, which can determine if the caretaker has washed their hands before and after the interaction with the patient. The hand hygiene monitoring system generates and compiles the performance data of all the caretakers to later take actions if missed washing hands. Hand hygiene monitoring systems are available with different features such as real-time activity, historical data, statistical representation, etc.

Hand Hygiene Monitoring System Market: Drivers and Restraints

Caretakers in hospitals and medical facilities are often preoccupied with a lot of work load and multitasking. The demand for hand hygiene monitoring systems is increasing because of their systematic and accurate control, significant reduction in spread of infection, easy implementation and cost effectiveness. The implementation of hand hygiene monitoring systems has increased, almost more than five folds reducing the number of cases of infectious diseases. Patient satisfaction and trust are the underlining benefits of hand hygiene monitoring systems.

Hand Hygiene Monitoring System Market: Segmentation

On the basis of product type, the hand hygiene monitoring systems market can be segmented into:

Devices/Sensors
Portable/Plug-in hand hygiene monitoring systems
Wall Mounted Devices hand hygiene monitoring systems
Software Solutions
On the basis of end user, the hand hygiene monitoring systems market can be segmented into:

Hospitals
Dialysis Centers
Clinics
Hand Hygiene Monitoring System Market: Overview

The global hand hygiene monitoring system market is expected to foresee exponential growth owing to increasing implementation of hand hygiene monitoring systems by hospitals and healthcare units. Recommendations and guidelines from government units and safety precautions laid by healthcare organisations subtly pressurize healthcare clinics and hospitals to implement hand hygiene monitoring systems. The number of players entering the hand hygiene monitoring systems market has increased, with advanced and latest technologies and features. The rising demand for hand hygiene monitoring systems is expected to boost the growth of the hand hygiene monitoring systems market. The hospitals segment is expected to account high CAGR in the hand hygiene monitoring system market over the forecast period. The requirement for hand hygiene monitoring systems is all around the globe but the market is dependent on the countries willing to adopt the systems.

Request Brochure of this Report @ https://www.factmr.com/connectus/sample?flag=B&rep_id=2277

Hand Hygiene Monitoring System Market: Regional Outlook

In terms of geography, the global hand hygiene monitoring system market is segmented into eight regions including North America, Eastern Europe, Western Europe, and Asia- Pacific excluding China & Japan (APECJ), China, Japan, Middle-East & Africa, and Latin America. North America is expected to be the most dominating market for hand hygiene monitoring system market due to the rise in per capita expenditure on healthcare and technological advancements. Western Europe is expected to witness fast growth in the global hand hygiene monitoring system market The Asia Pacific excluding China and Japan hand hygiene monitoring system market is expected to account high growth over the forecast period due to growing demand from hospitals and clinics. China and Japan are expected to gain significant shares in the global hand hygiene monitoring system market due to increase in demand as well as number of manufactures.

Hand Hygiene Monitoring System Market: Key Players

Examples of some of the key players operating in the global hand hygiene monitoring system market are Halma plc, Yamabiko Corporation, BioVigil Healthcare Systems, Inc., Deb Group Ltd., GOJO Industries, Inc., HandGiene Corp., Ecolab, Midmark Corporation, Stanley Black & Decker, Inc., and AiRISTA Flow (Halyard Health), among others.

The report covers exhaustive analysis on:

Market Segments
Market Dynamics
Market Size
Supply & Demand
Current Trends/Issues/Challenges
Competition & Companies involved
Technology
Value Chain
Regional analysis includes

North America
US
Canada
Latin America
Brazil
Mexico
Argentina
Chile
Peru
Rest of LATAM
Europe
EU – 4 (Germany, France, Italy, Spain)
UK
BENELUX (Belgium, Netherlands, Luxemburg)
NORDIC (Norway, Denmark, Iceland, Sweden)
Eastern Europe (Poland, Ukraine, Czech Rep. Etc.)
Rest of Europe
CIS & Russia
Japan
APEJ
Greater China
India
S. Korea
ASEAN Countries
Rest of APEJ
Middle East & Africa
GCC Countries
Turkey
Iran
Israel
South Africa
Rest of MEA
Report Highlights:

For more information on this report, please visit:https://www.factmr.com/report/2277/hand-hygiene-monitoring-system-market

About Fact.MR

For more information on this press release visit: http://www.sbwire.com/press-releases/hand-hygiene-monitoring-system-market-regulations-and-competitive-landscape-outlook-to-2018-to-2028-1111276.htm

Media Relations Contact

Sudip Shaha
Head of Marketing
Fact.MR
Telephone: 353-1-6111-593
Email: Click to Email Sudip Shaha
Web: https://www.factmr.com

Fact.MR has announced the addition of the “Necrotizing Skin infections Treatment Market Forecast, Trend Analysis & Competition Tracking - Global Market Insights 2018 to 2028"report to their offering.

Rockville, MD -- (SBWIRE) -- 12/26/2018 -- Necrotizing skin infections ranks among the most rarely found diseases but are highly lethal infection. Necrotizing skin infection arise primarily in any layer of skin soft tissue such as dermis and epidermis that are associated with necrotizing changes. Necrotizing skin infection is also commonly called as "Flesh eating disease". Necrotizing skin infections penetrates deeper layers of soft tissues and rapidly spreads along facial planes. This infection majorly infects the adipose tissue and deep musculature. Establishing the diagnosis of necrotizing skin infections is the greatest challenge for medical professionals. In some cases death can occur within 12 to 24 hrs if diagnosis and proper treatment is not provided in time. Progression of necrotizing skin infections differs from person to person depending on age, overall health, extent of symptoms etc. Common symptoms of necrotizing skin infection include onset of pain and swelling at the site of wound, nausea, ulcer, fever etc. Necrotizing skin infections includes various necrotizing forms of fasciitis, myositis and cellulitis. The treatment of necrotizing skin infections is surgically removal of dead and septic tissues and various range of antibiotics. For instance, dicloxacillin and cephalexin are recommended for treatment of necrotizing skin infections caused by group A streptococcus. Oral therapy is prescribed for superficial dermal necrotizing infections like vancomycin for S aureous. A comprehensive treatment plan may involve medications, physical and other types of therapy, and counseling. The major potential end users for necrotizing skin infection treatment market where these treatments are high in demand and generate significant revenues includes hospital associated hospitals, specialty clinic and ambulatory surgery centers and research institutes.

Necrotizing Skin Infection Treatment Market: Drivers and Restraints

The growing demand for effective cure indicated for necrotizing skin infections as current standard cure for necrotizing skin infections also involves surgical debridement unfortunately leading to amputations. To prevent loss of limb or fatal outcome need for new therapies in necrotizing skin infection market is expected to be the major factor driving the growth of the necrotizing skin infection market over the forecast period. Also, rapid discovery of novel therapy like hyperbaric oxygen therapy is further expected to drive the revenue growth in global necrotizing skin infection treatment. Increase in advance diagnostic technique for diagnosis of necrotizing skin infection like magnetic resonance imaging is also contributing to the growth of necrotizing skin infection treatment market. Approval and launch of new medicines by leading companies is the other important factor fueling to the growth of the global necrotizing skin treatment market. However, improper diagnosis of necrotizing skin infection is anticipated to restrain the revenue growth in global necrotizing skin infection treatment market. As early symptoms of necrotizing skin diseases are often mistaken for flu.

Get Free Exclusive Sample Copy of This Report @ https://www.factmr.com/connectus/sample?flag=S&rep_id=2278

Necrotizing Skin Infection Treatment Market: Segmentation

Tentatively, the global necrotizing skin infection treatment market can be segmented on the basis of treatment type, causative agent type, end user.

Based on treatment type, the global necrotizing skin infection treatment market is segmented as:

Surgery
Antibiotics
Based on causative agent type, the global bacterial antigens market is segmented as:

Group A Streptococcus
Bacterioides
Klebsiella
Clostridium
Coli
Staphylococcus aureus
Acromonas hydrophila
Based on end user, the global bacterial antigens market is segmented as:

Hospital
Ambulatory surgery centers
Specialty clinics
others
Necrotizing Skin Infection Treatment Market: Overview

The global market for necrotizing skin infection treatment is expected to register a moderate growth rate over the forecast period on the account of increase in number of diagnostic tests performed in humans. Different types of products are being introduced in the necrotizing skin infection treatment market recently by leading players such as anti-infective Aganocide compound for necrotizing skin infection known as Neutro phase skin and wound cleanser by Novabay pharmaceutical Inc., and some of the innovative surgical methods for treating severe cases of necrotizing skin infection are expected to come in the necrotizing skin infection treatment market. Thus there exists a high competition among local and regional players for necrotizing skin infection treatment market. According to CDC (center for Disease Control and Prevention) necrotizing fasciitis is caused majorly by group A streptococcus and is very common infection among necrotizing skin infections. Among the oral antibiotic treatment indicated for group A streptococcus, the Amoxicillin or cephalexin medicinal product segment is expected to lead the global necrotizing skin infection treatment market over the forecast period. Diagnostic laboratories and specialty clinics is expected to contribute high revenue share in the global necrotizing skin infection treatment market as they are the most significant platform to perform diagnostic tests and provide treatment for necrotizing skin infection. Hospital for treating necrotizing skin infections also account for significant revenue generation owing to large footprint of patients to get treated.

Request Brochure of this Report @ https://www.factmr.com/connectus/sample?flag=B&rep_id=2278

Necrotizing Skin Infection Treatment Market: Regional Outlook

Geographically, the global necrotizing skin infection treatment market is segmented into viz. North America, Latin America, Europe, Asia-Pacific excluding Japan (APEJ), Japan and the Middle East and Africa (MEA). North America is expected to be the leading market in the necrotizing skin infection treatment market owing to rise in number of patients for necrotizing skin infection as CDC stated that 1200 cases occurs each year in U.S since 2010 as compared to other regions. The necrotizing skin infection treatment market in Asia Pacific excluding Japan is expected to witness sluggish due to low treatment seeking rate. Europe is expected to register second largest share in the global necrotizing skin infection treatment market throughout the forecast period owing to increased funding for research and advance health care infrastructure the region.

Necrotizing Skin Infection Treatment Market: Key Players

The global necrotizing skin infection treatment market is fragmented with few number of domestic manufacturers. Examples of some of the key players operating in the global necrotizing skin infection treatment market are DURATA therapeutics, cubist Pharmaceutical, Wockhardt limited, Atox Bio Inc., Basilea pharmaceutical, AG and Melinta Therapeutics,Inc. and others.

The report covers exhaustive analysis on:

Market Segments
Market Dynamics
Market Size
Supply & Demand
Current Trends/Issues/Challenges
Competition & Companies involved
Technology
Value Chain
Regional analysis includes

For more information on this report, please visit:https://www.factmr.com/report/2278/necrotizing-skin-infections-treatment-market

About Fact.MR

For more information on this press release visit: http://www.sbwire.com/press-releases/necrotizing-skin-infections-treatment-market-latest-trends-demand-and-analysis-2018-to-2028-1111277.htm

Media Relations Contact

Sudip Shaha
Head of Marketing
Fact.MR
Telephone: 353-1-6111-593
Email: Click to Email Sudip Shaha
Web: https://www.factmr.com

Fact.MR has announced the addition of the “Oral & Topical Anaesthetics Market Forecast, Trend Analysis & Competition Tracking - Global Market Insights 2018 to 2028"report to their offering.

Rockville, MD -- (SBWIRE) -- 12/26/2018 -- Anesthesia is reversible loss sensation which is induces by a drug known as anesthetics. Amongst these drugs, Oral & Topical anesthetics are the drugs that reversibly block nerve conduction in and around the target site of administration, mainly in mouth or oral sites. Oral & Topical Anesthetics penetrate mucosal surfaces of mouth more easily than through a keratinized surface because of the absence of a stratum corneum (through the openings of the hair follicles and sweat glands. Oral & Topical anesthetics are being widely used in anesthesia, dentistry, and aesthetic surgery as they cause superficial loss of pain sensation after direct application. Local Oral & Topical Anesthetics remains major healthcare tool for pain control in anesthesia, oral and dentistry. However, research and development are still undergoing to seek new products in Oral & Topical Anesthetics market for managing the pain. Most of the Oral & Topical Anesthetics researches are focused on improvement in the area of anesthetic agents and route of administration such as gels, ointments, solutions and adhesive patches.

Oral & Topical Anaesthetics Market: Drivers and Restraints

Global Oral & Topical Anesthetics market is primarily driven by the increase in the incidences of dental associated problems and diseases. Some other driving factors in the Oral & Topical Anesthetics market include increase awareness amongst population about oral care, government healthcare initiatives and training programs, increase in dental patients, and oral cosmetic surgeries. Moreover, increase in the number of anesthesiologists and dentists globally, will also propel the growth of Oral & Topical Anesthetics market. However, stringent regulatory guidelines for drug approval, availability of skilled anesthesiologists and dentist, and side effects of anesthetic drugs may affect the growth of the global Oral & Topical Anesthetics market. In addition, poor healthcare infrastructure in low economic countries will impede growth Oral & Topical Anesthetics market over the forecast period.

Get Free Exclusive Sample Copy of This Report @ https://www.factmr.com/connectus/sample?flag=S&rep_id=2279

Oral & Topical Anaesthetics Market: Segmentation

Tentatively, the global Oral & Topical Anesthetics market can be segmented on the basis of drug class type, route of administration and duration of action.

Based on drug class type, the global Oral & Topical Anesthetics market is segmented as:

Non-aqueous
Ethyl aminobenzoate (benzocaine)
Lidocaine base
Eutectic mixture of lidocaine and prilocaine
Aqueous
Benzyl alcohol
Tetracaine hydrochloride
Lidocaine hydrochloride
Based on Route of Administration, the global Oral & Topical Anesthetics market is segmented as:

Gels
Ointments
Solutions
Adhesive patch
Based on duration of action, the global Oral & Topical Anesthetics market is segmented as:

Short
Medium
Long
Based on Distribution Channel, the global Oral & Topical Anesthetics market is segmented as:

Hospitals
Dental Clinics
Pharmacies and drug stores
E-commerce
Oral & Topical Anaesthetics Market: Overview

Globally, Oral & Topical Anesthetics market will witness growth due to many factors which includes emergence of new drug products in oral tropical care, increase in dental patients, rise and awareness in disposable income in developing nations, demand oral care, and need for improved and less painful anesthetic administration. According to The Lancet Commission on Global Health 2015, around 5 billion people worldwide lack access to surgical and an aesthetic care, most of these are in lower income countries. Therefore leading drug manufacturers are focused to provide new and innovative generic Oral & Topical Anesthetics drugs which will not only improve the painless treatment but also incur low medical costs. Furthermore, entering of new players into Oral & Topical Anesthetics is also expected to create a healthy competitive environment in the global Oral & Topical Anesthetics market during the forecast period.

Request Brochure of this Report @ https://www.factmr.com/connectus/sample?flag=B&rep_id=2279

Oral & Topical Anaesthetics Market: Regional Outlook

Region-wise, the global Oral & Topical Anesthetics market is classified into regions namely North America, Latin America, Europe, CIS & Russia, Japan, Asia Pacific Excluding Japan, ASEAN Countries, Middle East and Africa. North America is will lead the Oral & Topical Anesthetics market due to high healthcare investments, presence major pharmaceutical research hubs and high standard of living. The European Oral & Topical Anesthetics market will be the second largest market and will flourish thanks to the increasing number of medical professionals and growing awareness. The steady increase in the number of dentists and anesthesiologist in Europe specifically in Germany, France, U.K and Italy will propel the market growth of Oral & Topical Anesthetics Market in the region. Asia Pacific will be the fastest growing Oral & Topical Anesthetics market as it comprises of large and small healthcare entities which provides scope for healthy competition and growth opportunity. Latin America Oral & Topical Anesthetics market is expected to hold the fifth largest market share after Asia Pacific due to increasing trend towards competitive environment amongst drug manufacturers and medical awareness among the population. Japan, being a developed economy will have the major contribution in Oral & Topical Anesthetics market. However, CIS & Russia will have moderate growth in Oral & Topical Anesthetics Market due to average customer base. The Middle East and Africa will hold the lowest share of Oral & Topical Anesthetics market, owing to average medical facilities, poor political environment in Africa and low funding.

Oral & Topical Anaesthetics Market: Key Players

Some of the key players operating in the global Oral & Topical Anesthetics anesthesia market are Astra Zeneca (UK), Septodont (US), Dentsply (US), Sirona (US), GlaxoSmithKline PLC (US), Gilead Sciences Inc. (US), Johnson & Johnson (US), F. Hoffmann-La Roche Ltd. (Switzerland), Baxter International Inc. (US), Abbott Laboratories (US), Hospira, Inc. (US), Hikma Pharmaceuticals PLC (UK), AbbVie Inc. (US), Fresenius Se & Co. Kgaa (Germany), and others.

The report covers exhaustive analysis on:

Market Segments
Market Dynamics
Market Size
Supply & Demand
Current Trends/Issues/Challenges
Competition & Companies involved
Technology
Value Chain
Regional analysis includes

For more information on this report, please visit:https://www.factmr.com/report/2279/oral-topical-anaesthetics-market

For more information on this press release visit: http://www.sbwire.com/press-releases/oral-topical-anaesthetics-market-trends-and-segments-2018-to-2028-1111278.htm

Media Relations Contact

Sudip Shaha
Head of Marketing
Fact.MR
Telephone: 353-1-6111-593
Email: Click to Email Sudip Shaha
Web: https://www.factmr.com

Fact.MR has announced the addition of the “Automated Dialysis Concentrated Production Systems Market Forecast, Trend Analysis & Competition Tracking - Global Market Insights 2018 to 2028"report to their offering.

Rockville, MD -- (SBWIRE) -- 12/26/2018 -- Dialysis is a medical procedure which removes excess solutes, water, and toxins from the blood. It is preferred for patients dealing with kidney diseases and related ailments. According to the National Institute of Diabetes and Digestive and Kidney Diseases, in 2015, there were approximately 661,000 Americans who had kidney failure, and 468,000 among these went through dialysis. Dialysis concentrates contain a mixture of glucose, electrolytes, and purified water. The concentrate resembles the concentration occurring naturally in the blood beside buffer and potassium. Dialysis concentrates are prepared according to the patient's requirement and help in regulating their acid-base and electrolyte balance and removing metabolic waste products from the blood. Automated dialysis concentrated production systems are used to produce these concentrates. The production in the automated dialysis concentrated production systems include bicarbonate concentrate production, acid concentrate production, and specific modifiers for hemodialysis. Automated dialysis concentrated production systems have storage tanks and mixing tanks where the dialysis concentrates are prepared. The storage tanks in an automated dialysis concentrated production system are connected to the delivery systems for dialysis centers.

Automated Dialysis Concentrated Production Systems Market: Drivers

Automated dialysis concentrated production systems market is highly driven by growing incidences of chronic kidney diseases and kidney-related ailments. Increase in private investment and venture funding as support to the manufacturing of more advanced production systems is also expected to drive the automated dialysis concentrated production systems market over the forecast period. Government spending on health care, especially for patients dealing with chronic kidney diseases has been improving and could drive the demand for automated dialysis concentrated production systems over the forecast period. However, there is low awareness about kidney-related ailments which might hinder market growth for automated dialysis concentrated production systems. The procedure is also costly, making it highly unaffordable for middle-income and poor-economy countries. This could also hinder the automated dialysis concentrated production systems market over the forecast period.

Get Free Exclusive Sample Copy of This Report @ https://www.factmr.com/connectus/sample?flag=S&rep_id=2280

Automated Dialysis Concentrated Production Systems Market: Segmentation

Tentatively, the global automated dialysis concentrated production systems market can be segmented as per dialysis type, end user, and geography.

Based on dialysis type, the global automated dialysis concentrated production systems market is segmented into:

Automated Dialysis Concentrated Production Systems for Hemodialysis
Automated Dialysis Concentrated Production Systems for Peritoneal Dialysis
Automated Dialysis Concentrated Production Systems for Continuous Renal Replacement Therapy
Based on product type, the global automated dialysis concentrated production systems market is segmented into:

Open Automated Dialysis Concentrated Production Systems
Closed Automated Dialysis Concentrated Production Systems
Based on end users, the global automated dialysis concentrated production systems market is segmented into:

Hospitals
Specialized Clinics
Renal Care Centers
Others
Based on geography, the global automated dialysis concentrated production systems market is segmented into:

North America
Latin America
Europe
CIS & Russia
Japan
APEJ
Middle East & Africa
Automated Dialysis Concentrated Production Systems Market: Overview

Automated dialysis concentrated production systems market is highly driven by hemodialysis. Hemodialysis is one of the most common dialysis methods performed for patients suffering from chronic kidney diseases and related ailments. According to the National Center for Chronic Disease Prevention and Health Promotion, there were approximately 118,000 people in the US in 2014 who started the treatment for ESRD and 662,000 were on chronic dialysis or had a kidney transplant. Open automated dialysis concentrated production system is expected to grow at the fastest rate owing to a better and improved validation of the dialysis fluid and water treatment and production of fluid according to the required quality.

Request Brochure of this Report @ https://www.factmr.com/connectus/sample?flag=B&rep_id=2280

Automated Dialysis Concentrated Production Systems Market: Regional Outlook

A vital factor which is driving the North America market for automated dialysis concentrated production systems is the growing awareness about the availability of automated dialysis concentrated production systems for treatment of various kidney diseases and kidney related ailments. North America's automated dialysis concentrated production systems market is also expected to grow at a faster rate owing to good healthcare spending and healthcare infrastructure. Europe is one of the leading regions for automated dialysis concentrated production systems market because of the high incidence and prevalence of kidney diseases and consistent rise in geriatric population. Lack of awareness about kidney diseases and dialysis will hinder the Asia-Pacific's market for automated dialysis concentrated production systems over the forecast period.

Automated Dialysis Concentrated Production Systems Market: Key Players

The major market participants operating in the global automated dialysis concentrated production systems market are B. Braun Melsungen AG, REN MED MEDICAL PRODUCTS & TRADE LTD. CO., Nipro Renal Solutions, Unipharm JSC, and FLG Automation AG.

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts and inputs from industry experts and industry participants across the value chain. The report provides an in-depth analysis of parent market trends, macro-economic indicators, and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

The report covers exhaustive analysis on:

Market Segments
Market Dynamics
Market Size
Supply & Demand
Current Trends/Issues/Challenges
Competition & Companies involved
Technology
Value Chain
Regional analysis includes:

North America
US
Canada
Latin America
Brazil
Mexico
Argentina
Chile
Peru
Rest of LATAM
Europe
EU – 4 (Germany, France, Italy, Spain)
UK
BENELUX (Belgium, Netherlands, Luxemburg)
NORDIC (Norway, Denmark, Iceland, Sweden)
Eastern Europe (Poland, Ukraine, Czech Rep. Etc.)
Rest of Europe
CIS & Russia
Japan
APEJ
Greater China
India
Korea
ASEAN Countries
Rest of APEJ
Middle East & Africa
GCC Countries
Turkey
Iran
Israel
South Africa
Rest of MEA
Report Highlights:

Detailed overview of parent market
Changing market dynamics in the industry
In-depth market segmentation
Historical, current, and projected market size in terms of volume and value
Recent industry trends and developments
Competitive landscape
Strategies of key players and products offered
Potential and niche segments, geographical regions exhibiting promising growth
A neutral perspective on market performance
Must-have information for market players to sustain and enhance their market footprint.

For more information on this report, please visit:https://www.factmr.com/report/2280/automated-dialysis-concentrated-production-systems-market

For more information on this press release visit: http://www.sbwire.com/press-releases/automated-dialysis-concentrated-production-systems-market-growth-with-worldwide-industry-analysis-2018-to-2028-1111279.htm

Media Relations Contact

Sudip Shaha
Head of Marketing
Fact.MR
Telephone: 353-1-6111-593
Email: Click to Email Sudip Shaha
Web: https://www.factmr.com

Fact.MR has announced the addition of the “ENT Cameras Market Forecast, Trend Analysis & Competition Tracking - Global Market Insights 2018 to 2028"report to their offering.

Rockville, MD -- (SBWIRE) -- 12/26/2018 -- ENT cameras are generally meant to be used along treatment of various problems that goes around the ear, nose and throat region. These organs are meant for some of the most important functions in a human body so it remains very essential to keep them functioning properly. ENT Cameras play a major role in diagnosing as well as assisting during a procedure and in many cases it is the sole operative tool. ENT Cameras is guided through an endoscope which creates images and videos of the affected region. ENT Cameras is being used in various clinical and surgical settings to include sinonasal endoscopy, bronchoscopy, otoscopy and laryngoscopy. ENT Cameras provides a high resolution image of the affected region and requires light source to capture one image. Light source is attached to the endoscope through which ENT Cameras is attached and then passed through the body part in order to perform the procedure.

ENT Cameras market: Drivers and Restraints

ENT cameras are meant for some serious treatment regions which makes it a rather important market to invest in as the market is continuous in its approach and need. The market is driven by the increasing number of reported ENT disorders. Technology has led the market to adopt new methods in order to build ENT Cameras which are minimally invasive in its approach as the rush for minimally invasive methods in healthcare sectors is rising. The ENT cameras are increasingly getting adopted accustomed to the cosmetic advancements. Technological advancements for interventional ENT devices has led the ENT Cameras market to be more involved with patients and more quality offered from the companies factors in creating a positive impact in the market. But the social stigma still remains the same for labelling it rather expensive that might hinder the market for ENT camera. Digital photography has always remained more in favour than analog photography in clinical practices.

Get Free Exclusive Sample Copy of This Report @ https://www.factmr.com/connectus/sample?flag=S&rep_id=2281

ENT Cameras market: Segmentation

Tentatively, the global ENT Cameras market can be segmented on the basis of Product, Modality, End User and Geography.

Based on product Type, the global ENT Cameras Market is segmented as:

Camera System
Video System
Based on Modality, the global ENT Cameras Market is segmented as:

Portable
Stand alone
Based on End User, the global ENT Cameras Market is segmented as:

Hospital
Specialty clinic
Ambulatory surgical center
ENT Cameras market: Overview

The global market for ENT Cameras is expected to witness moderate growth over the forecast period due to its market presence in the present world but with technological advancements also effecting ENT Cameras market the product availability and exposure might get effected. Majority of the growth is related to the rising number of ENT Cameras used in reported cases, surgical treatments are performed using ENT Cameras in the generic market and thus there exists a high competition among local and regional players to develop products that are highly compatible and useful to majority of users. Among the Product types, the ENT camera's video system segment is expected to grow in the global ENT Cameras market over the forecast period due to its substantial quality over all surgical procedures. Portable units are more in demand due to their manageable outlook and is expected to contribute high share in the global ENT Cameras market. Thus, with high adoption and technical shifts in ENT cameras, there falls a positive scope for the market to grow with better advanced products lined up.

Request Brochure of this Report @ https://www.factmr.com/connectus/sample?flag=B&rep_id=2281

ENT Cameras market: Regional Outlook

Geographically, the global ENT Cameras market is segmented into North America, Latin America, Europe, CIS & Russia, Asia-Pacific excluding Japan (APEJ), Japan and the Middle East and Africa (MEA). North America is expected to be the dominant market in the global ENT Cameras market owing to the progressive healthcare infrastructure and leading manufacturers. The ENT Cameras market in Asia Pacific excluding Japan is expected to provide offerings by the key players and domestic players of the region. Europe is expected to have a large share in the global ENT Cameras market throughout the forecast period due to its quality healthcare facilities and public awareness related to ENT Camera.

ENT Cameras market: Key Players

The global market for ENT Cameras is fragmented with different sources. Examples of some of the key players operating in the global ENT Cameras market are Johnson & Johnson Vision Care Inc., SynergEyes Inc., Luxottica, all2md, DP Medical Systems Ltd, Global Surgical Corporation, The Cooper Companies Inc., SOPRO-COMEG, ATMOS MedizinTechnik GmbH & Co., Olympus, Essilor International, ZEISS International and more which are producing some variant of ENT Camera.

The report covers exhaustive analysis on:

Market Segments
Market Dynamics
Market Size
Supply & Demand
Current Trends/Issues/Challenges
Competition & Companies involved
Technology
Value Chain
Regional analysis includes

North America
US
Canada
Latin America
Brazil
Mexico
Argentina
Chile
Peru
Rest of Latin America
Europe
EU – 4 (Germany, France, Italy, Spain)
UK
BENELUX (Belgium, Netherlands, Luxemburg)
NORDIC (Norway, Denmark, Iceland, Sweden)
Eastern Europe (Poland, Ukraine, Czech Rep. etc.)
Rest of Europe
CIS & Russia
Japan
APEJ
Greater China
India
Korea
ASEAN Countries
Rest of APEJ
Middle East & Africa
GCC Countries
Turkey
Iran
Israel
South Africa
Rest of MEA
Report Highlights:

For more information on this report, please visit:https://www.factmr.com/report/2281/ent-cameras-market

About Fact.MR

For more information on this press release visit: http://www.sbwire.com/press-releases/ent-cameras-market-with-current-trends-analysis-2018-to-2028-1111280.htm

Media Relations Contact

Sudip Shaha
Head of Marketing
Fact.MR
Telephone: 353-1-6111-593
Email: Click to Email Sudip Shaha
Web: https://www.factmr.com

Fact.MR has announced the addition of the “Neuro Ablation Devices Market Forecast, Trend Analysis & Competition Tracking - Global Market Insights 2018 to 2028"report to their offering.

Rockville, MD -- (SBWIRE) -- 12/26/2018 -- Neuro ablation devices are medical devices that are applied to iatrogenic Peripheral Nerve Injury (PNI). A peripheral nerve is composed of axon, myelin, endoneurium, fascicle, perineurium and epineurium. The individual myelinated axons and groups of unmyelinated axons are usually surrounded by the endoneurium. Currently available neuro ablation devices focus on precise and target-oriented denervation. Recurrence of pain after a short period is always a problem in pain practice. Recurrence of pain indicates nerve regeneration after peripheral nerve injury. It is suggested that the current neuro ablations produce a third degree peripheral nerve injury to the myelin, axon and endoneurium without the disruption of the fascicular arrangement, perineurium and epineurium. The objective is to produce a reversible injury, however, its shortcomings are the recurrence of pain and the necessity to repeat the ablative procedure. Neuro ablation devices in the current practices can be categorised into chemical and physical (electromagnetic and thermal) neurolysis. Both of these methods produce nerve injury and result in the degeneration of nerve fibres form the distal to the lesion along with its myelin sheath, also known as "Wallerin degeneration."

In clinical practice, neuro ablation devices lead to nerve regeneration after ablation based on the thickness of the tactile sense, motor, proprioception, temperature, pain and sympathetic tone. However, patients experience an itching sensation without pain, and it recurs at first without the recurrence of pain.

Neuro Ablation Devices Market: Drivers and Restraints

The growing prevalence of back pain, spinal injuries, neurological disorders and cancers is expected to be a major factor driving the neuro ablation devices market over the forecast period. For instance, more than 80% of the global population experiences lower back pain at-least once in their life. At any given time, lower back pain is prevalent in 4% to 33% of the population. Lower back is one of the leading reasons responsible for significant resource utilisation, accounting for over $100 billion annually in the U.S. However, the need for trained professionals and the high prices of procedures are among factors hinders the growth of the neuro ablation devices market.

Get Free Exclusive Sample Copy of This Report @ https://www.factmr.com/connectus/sample?flag=S&rep_id=2283

Neuro Ablation Devices Market: Segmentation

The global neuro ablation devices market has been segmented on the basis of product type, indication, end users and geography.

Based on product type, the global neuro ablation devices market is segmented as:

Alcohol Neurolysis
Radiofrequency Ablation (RFA)
Thermal RFA
Pulsed RFA
Based on indication, the global neuro ablation devices market is segmented as:

Spinal Joint pain
Visceral Cancer Pain
Axial Back/neck pain
Radicular neck/back pain
Trigeminal neuralgia
Occipital neuralgia
Others
Based on end users, the global neuro ablation devices market is segmented as:

Hospitals
Specialty Clinics
Academic and Research Centres
Neurosurgery Centres
Neuro Ablation Devices Market: Overview

The global neuro ablation devices market is expected to witness moderate growth over the forecast period. The neuro ablation devices can be broadly classified based on procedure type as traditional alcohol neurolysis neuro ablation devices and radiofrequency neuro ablation devices. Radiofrequency neuro ablation devices are further sub-segmented into thermal neuro ablation devices and pulsed neuro ablation devices. Neuro ablation devices are indicated for various conditions, which include spinal joint pain, visceral cancer pain and neuralgia condition, among others. The main end users of neuro ablation devices are hospitals, neurosurgery centres and academic & research centres.

Request Brochure of this Report @ https://www.factmr.com/connectus/sample?flag=B&rep_id=2283

Neuro Ablation Devices Market: Regional Outlook

Geographically, the global neuro ablation devices market is segmented into North America, Latin America, Europe, Asia-Pacific excluding Japan (APEJ), CSI & Russia, Japan and the Middle East and Africa (MEA). North America is expected to be the dominant market in the global neuro ablation devices market owing to the availability of technologically advanced products, high awareness among the general public and increasing healthcare spending. The neuro ablation devices market in Asia Pacific excluding Japan is expected to grow at a significant CAGR due to increased R&D spending and advancements in technology.

Neuro Ablation Devices Market: Key Players

The global market for neuro ablation devices is highly fragmented. Some of the key players operating in the global neuro ablation devices market are Medtronic Plc, Biosense Webster Inc. (Sub. Of Johnson & Johnson), St. Jude Medical, Boston Scientific Corporation, Angiodynamics Inc., Articulture Inc., Conmed Corporation, Olympus Corporation, Smith & Nephew and Galil Medical Inc. (acquired by BTG International Ltd).

The report covers exhaustive analysis on:

Market Segments
Market Dynamics
Market Size
Supply & Demand
Current Trends/Issues/Challenges
Competition & Companies involved
Technology
Value Chain
Regional analysis includes

North America (U.S., Canada)
Latin America (Mexico, Brazil, Argentina, Chile, Peru, Rest of LATAM)
Europe (EU-4(Germany, France, Italy, Spain), U.K., BENELUX, NORDIC, Eastern Europe, Rest of Europe)
CIS & Russia
Japan
APEJ (Greater China, India, S. Korea, ASEAN Counties, Rest of APEJ)
Middle East & Africa (GCC Counties, Turkey, Iran, Israel, South Africa, Rest of MEA)
Report Highlights:

For more information on this report, please visit:https://www.factmr.com/report/2283/neuro-ablation-devices-market

For more information on this press release visit: http://www.sbwire.com/press-releases/neuro-ablation-devices-market-segments-and-key-trends-2018-to-2028-1111281.htm

Media Relations Contact

Sudip Shaha
Head of Marketing
Fact.MR
Telephone: 353-1-6111-593
Email: Click to Email Sudip Shaha
Web: https://www.factmr.com

Fact.MR has announced the addition of the “Durometers Market Forecast, Trend Analysis & Competition Tracking - Global Market Insights 2018 to 2028"report to their offering.

Rockville, MD -- (SBWIRE) -- 12/26/2018 -- Introduction of Durometer Market

Durometers are devices which are used for the measuring the hardness of the materials such as rubbers, elastomers, polymers. The device i.e. durometer tests the depressions of different materials which is measured by applying a defined force. The depth of the depression reflects the hardness of the material. Different materials such as plastics, metals, rubber, fabrics and foams are measured using different types of scales of hardness such as type A and type C. for example type A scale measures soft plastic materials while type D scale is used to measure hard plastics. There are a number of testing standards and units such as the Brinnell scale, the Rockwell scale and Leeb rebound hardness level, for example to measure the foam hardness or soft plastics Shore A and Shore S are used. Moreover durometers are also called as Shore durometers due to their popularity. Also to check the hardness of very thin and small materials or may be while measuring small regions of a sample micro hardness testing is performed which is another type to check the hardness of the samples. With the technology advancement the manufactures have manufactured hand held portable and compact durometers which are digital and equipped with internal memory which will take the measurements with accuracy and in minimum possible time.

Factor driving the Durometers Market

Durometers market is primarily driven by the technological advancements and digitization. The devices are used to measure the cushions of the wheel chairs, medical pads, injection seals with silicon septas, rubber stoppers which are used in laboratories, also they are used in minimally invasive devices and many more devices. With the increasing number of geriatric population and prevalence of diseases around the world manufacturing of new devices and techniques are driving the market as the new techniques are highly accurate, more efficient and take less time. The digital durometer takes the measurements without the use of cables, has an internal memory which saves the data and with the features such as USB interface can transfer the data into another device. Moreover with the increase in the laboratory activates there has been a significant adoption of durometers.

Get Free Exclusive Sample Copy of This Report @ https://www.factmr.com/connectus/sample?flag=S&rep_id=2287

Regional Market Outlook

Geographically, Durometers market is segmented into North America, Latin America, Europe, Asia-Pacific, and Middle East & Africa and Japan. The market in North America is expected to dominate the Durometers globally followed by Europe, North America is the dominant Durometers market due to the technological advancements and increasing research and development, laboratory procedures. Moreover in regions such as North America and Europe the hospitals and surgical centers opt for new technological methods to improve the treatment methodology due to strict regulations for patient care and safety, the durometers check the depression of the material to check its hardness . The market of durometer in Asia Pacific region is expected to grow at a higher rate with its increased acceptance and growing geriatric population who require advanced and accurate products. In addition, Asia pacific regions will grow due to rising healthcare expenditure in order to increase the patient compliance which will further increase the growth of the durometer market. With the availability of devices and instruments in regions such as Asia Pacific and Latin America the market of durometers is going to further spur revenue growth during the forecast period.

Some of the major players identified in Durometers Market are PTC Instruments, Rex Gauge Company, Inc., , TECLOCK Corporation, IMADA, Incorporated, Hildebrand Pruef- und Messtechnik GmbH, INSIZE CO., LTD, Buehler, Elcometer Limited, PCE Deutschland GmbH, Mitutoyo America Corporation, ZwickRoell , Struers, INNOVATEST Europe BV and Shimadzu Corporation. Also they are mainly focused to strengthen the core competencies of their product portfolio.

Durometers Market: Segmentation

Tentatively, the global Durometers Market has been segmented on the basis of Product type, Application, End User and geography.

Based on Product Type, the global Durometers Market is segmented as:

TYPE A Durometer - Soft rubber, plastics, polyurethane
TYPE B Durometer - Harder elastomers & plastics, Paper & fibrous, thermoplastic
TYPE C Durometer - Medium hard elastomers and plastics
TYPE D Durometer - Hard rubber & plastics , flooring
TYPE DO Durometer - granular material
TYPE O Durometer - soft elastomers
TYPE OO Durometer - sponge rubber gels, Light foams
TYPE OOO Durometer - Ultra soft gels and sponge rubber
TYPE M Durometer - thin materials such as rubber (not less than 1.25mm thick)
Others - cellular material, gel-like, foam rubber and sponge rubber
Based on Application, the global Durometers Market is segmented as:

Medical pads
Wheel chair cushions
Wound Threads
Implants ( such as breast Implants)
Based on End User, the global Durometers Market is segmented as:

Hospitals
Ambulatory surgical centers
Clinics
Laboratories
Long-term care centers
Based on Region, the global Durometers Market is segmented as:

North America
Latin America
Western Europe
Eastern Europe
Asia Pacific Excluding China and Japan
Japan
China
Middle East & Africa

Request Brochure of this Report @ https://www.factmr.com/connectus/sample?flag=B&rep_id=2287
Key data points covered in report

The report covers exhaustive analysis on:

Durometers Market by target areas, Product type, end user and region
Regional level market analysis of North America, Latin America, Europe, Asia Pacific, Middle East & Africa by method type, end user and country segments
Durometers market Dynamics & Opportunity Assessment
Historical Actual Market Size, 2013 - 2017
Durometers market system market Size & Forecast 2018-2028
Durometers Market Current Trends/Issues/Challenges
Competition & Companies involved
Report Highlights:

Shifting Industry dynamics
In-depth market segmentation
Historical, current and projected industry size Recent industry trends
Key Competition landscape, market structure, regulatory scenario
Epidemiology outlook for diseases
Economical spending, regional healthcare outlook, consumer healthcare expenditure
Availability of device, cost of the test, specificity and sensitivity
Strategies for key players and product offerings, Channel strategies, regional foot print, channel footprint
Potential and niche segments/regions exhibiting promising growth
A neutral perspective towards market performance in terms of value and volume

For more information on this report, please visit:https://www.factmr.com/report/2287/durometers-market

About Fact.MR

For more information on this press release visit: http://www.sbwire.com/press-releases/durometers-market-opportunities-demand-and-forecasts-2018-to-2028-1111282.htm

Media Relations Contact

Sudip Shaha
Head of Marketing
Fact.MR
Telephone: 353-1-6111-593
Email: Click to Email Sudip Shaha
Web: https://www.factmr.com

Fact.MR has announced the addition of the “Neuro Critical Care Market Forecast, Trend Analysis & Competition Tracking - Global Market Insights 2018 to 2028"report to their offering.

Rockville, MD -- (SBWIRE) -- 12/26/2018 -- Neuro critical care is an emerging field that combines the specialties that link neurology, neurosurgery, and critical care. Just as the field has evolved from primary focus on post-operative care to elective neurosurgical patients, the focus towards the resuscitation of neurological emergency cases such as traumatic brain injury or subarachnoid hemorrhage, which remain a clinical challenge. The neuro critical care market is strongly driven by the increasing focus, awareness, and prevalence of neurological impediments such as ischemic stroke, intracerebral hemorrhage, aneurysm, and other neurological disorders. According to the Center for Disease Control and Prevention (CDC), around 1.7 million persons sustain a traumatic brain injury every year, and around 120,000 have long-standing and substantial loss of function.

There are a number of equipment used for the diagnosis and monitoring of neurological injuries and disorders. Computed tomography (CT), magnetic resonance imaging (MRI) and electroencephalography (EEG) are some of the diagnostic equipment used in neuro critical care centers. A CT scan is generally used to locate or determine the location of the brain injury, while an MRI is used for further in-depth brain imaging for better assessment and diagnosis. Most equipment used in neuro critical care centers consist of life support and emergency devices, which includes monitoring systems such as CNS monitors, CNS video cameras, CNS readers, ventilators, and other accessories such as infusion pumps and catheters.

Advanced monitoring techniques used in neuro critical care allows the early identification of neurological injuries before permanent brain damage occurs. Neuro critical care also offers patients with specialized therapeutic and management options to achieve favorable outcomes. In North America, there are around 25 academic neuro critical care centers that cater to the needs of neurological patients.

Neuro Critical Care Market: Drivers and Restraints

The rising incidences of stroke and head trauma will boost the growth of the market. Increasing advances in neurosurgical techniques owing to the rising need for neuro critical care is expected to be a major factor driving the growth of the neuro critical care market over the forecast period. The rise in the incidences of brain tumors is another strong driving force in the industry, to provide more neuro critical care centers, thereby driving the growth of the neuro critical care market. Increasing advancements in technology on the neurosurgical front owing to the rising need of neuro critical care is expected to boost its market growth considerably during the forecast period. However, insufficient staff and need for specially trained professionals hinder the growth of the market substantially. The high cost involved in the establishment of a neuro critical care unit and the increased cost of in-patient in a neuro critical care center may hinder the growth of the neuro critical care market over the forecast period.

Get Free Exclusive Sample Copy of This Report @ https://www.factmr.com/connectus/sample?flag=S&rep_id=2284

Neuro Critical Care Market: Segmentation

Tentatively, the global neuro critical care market can be segmented on the basis of equipment type, indication, end user, and geography.

Based on equipment type, the global neuro critical care market is segmented as:

Diagnostics
Computed Tomography
Magnetic Resonance Imaging
Electroencephalography
Monitoring
CNS Monitors
CNS Device Interfaces
CNS Advance ICU Amplifiers
CNS Video Cameras
CNS Readers
Ventilators
Others
Based on indication, the global neuro critical care market is segmented as:

Subarachnoid Hemorrhage
Intracerebral Hemorrhage
Traumatic Brain Injury
Ischemic Stroke
Spinal Cord Injury
Infections of the Brain and Spinal Cord
Neuromuscular Disorders
Status Epilepticus
Brain Tumors
Based on end user, the global neuro critical care market is segmented as:

Hospitals
Emergency Centers
Specialty Clinics
Neuro Critical Care Market: Overview

The global neuro critical care market is expected to witness moderate growth over the forecast period. Neuro critical care can be broadly classified based on equipment type as diagnostic equipment and monitoring equipment. With respect to end users, the market is segmented into hospitals, emergency centers, and specialty clinics. The hospitals segment governs a major share of the market. However, specialty clinics is a fast growing segment in the neuro critical care market. This is due to an increase in the number of patients preferring specialty clinics for personalized care.

Request Brochure of this Report @ https://www.factmr.com/connectus/sample?flag=B&rep_id=2284

Neuro Critical Care Market: Regional Outlook

Geographically, the global neuro critical care market is segmented into North America, Latin America, Europe, Asia Pacific excluding Japan (APEJ), CSI & Russia, Japan, and the Middle East and Africa (MEA). North America is expected to be the dominant market in the global neuro critical care market, owing to the increasing incidence of stroke cases, and increasing healthcare and R&D spending in the region. The neuro critical care market in Asia Pacific excluding Japan is expected to grow at a significant CAGR, due to increased R&D spending and advancements in technology.

Neuro Critical Care Market: Key Players

The global market for neuro critical care is highly fragmented. Examples of some of the key players operating in the global neuro critical care market are Abbott, Teleflex Incorporated, Aspect Medical Systems, Inc., CardioDynamics International Corporation, Medtronic, General Electric Company, Edwards Lifesciences Corporation, Integra LifeSciences Corporation., Philips N.V., Draegerwerk AG & Co. KGaA, and Terumo Medical Corporation, among others.

The report covers exhaustive analysis on:

Market Segments
Market Dynamics
Market Size
Supply & Demand
Current Trends/Issues/Challenges
Competition & Companies Involved
Technology
Value Chain
Regional analysis includes:

For more information on this report, please visit:https://www.factmr.com/report/2284/neuro-critical-care-market

For more information on this press release visit: http://www.sbwire.com/press-releases/neuro-critical-care-market-growth-trends-and-value-chain-2018-to-2028-1111283.htm

Media Relations Contact

Sudip Shaha
Head of Marketing
Fact.MR
Telephone: 353-1-6111-593
Email: Click to Email Sudip Shaha
Web: https://www.factmr.com

Fact.MR has announced the addition of the “Ultrasound Skin Cleaners Market Forecast, Trend Analysis & Competition Tracking - Global Market Insights 2018 to 2028"report to their offering.

Rockville, MD -- (SBWIRE) -- 12/26/2018 -- Ultrasound skin cleaners use high levels or sound wave technology to penetrate deep below the surface of the skin promoting cellular renewal and repair, increasing blood circulation, toning muscles, encouraging lymphatic drainage, combating puffiness, swelling and improving skin care product penetration. Ultrasound skin cleaners may be used on most parts of the body, including the arms, neck, stomach, waist, hips, legs and buttocks. Ultrasound skin cleanser utilizes ultrasonic frequency and is commonly used by salon professionals to increase cellular turnover, tighten enlarged pores, improve acne, freckles, reduce the cellulite appearance and even repair scar damage. The process of is usually safe, gentle and painless and can also be used by people who have sensitive skin. Ultrasound skin cleaners are also available for home care settings.

When the ultrasound enters the body through the ultrasound skin cleaners, it reacts in many ways. It gets absorbed by the muscles, tendons and bones. Hard surfaces such as the bone would absorb and reflect the ultrasonic waves. All the conditions play a vital role in the eventual temperature rise in the surrounding tissues. This in turn increases the oxygen demand of the cells and helps in the removal of waste products. This antibacterial cleaning helps in preventing acne and skin and blemishes and the skin is instantly rosy, energized, firm and fresh.

In order to optimize the penetration of ultrasound skin cleaners, a conductive gel is usually used. Other than improving conductivity, the gel also penetrates deep into the skin. Estheticians generally use quality optimized gels that contain skin-firming ingredients.

Ultrasound Skin Cleaners Market: Drivers and Restraints

The rising popularity of skin care products and the increasing awareness of social standards for appearance amongst individuals are some of the major factors driving the growth of the ultrasound skin cleaners market. The flourishing entertainment industry and the increasing expenditure on personalized healthcare by the general population are some of the other factors fueling the growth of the ultrasound skin cleaners market.

Get Free Exclusive Sample Copy of This Report @ https://www.factmr.com/connectus/sample?flag=S&rep_id=2286

Ultrasound Skin Cleaners Market: Segmentation

Tentatively, the global ultrasound skin cleaners market can be segmented on the basis of product type, treatment area, distribution channels, and geography.

Based on product type, the global Ultrasound Skin Cleaners Market is segmented as:

Ultrasound Skin Scrubber
Ultrasound Skin Spatula
Based on treatment area, the global Ultrasound Skin Cleaners Market is segmented as:

Body Area
Facial Area (Cheeks, Forehead, Chin)
Delicate Eye Area
Based on distribution channels, the global Ultrasound Skin Cleaners Market is segmented as:

Pharmacies
Retail Pharmacies
Retail Stores
Drug Stores
E-commerce
Ultrasound Skin Cleaners Market: Overview

The global ultrasound skin cleaners market is expected to witness a considerable growth over the forecast period. The ultrasound skin cleaners can be broadly classified based on product type as ultrasound skin scrubber and ultrasound skin spatula. Ultrasound skin cleaners are indicated for various treatment areas like the eyes, cheeks, forehead, and chin. The main distribution channels of ultrasound skin cleaners are Drug stores, retain stores, and E-commerce.

Request Brochure of this Report @ https://www.factmr.com/connectus/sample?flag=B&rep_id=2286

Ultrasound Skin Cleaners Market: Regional Outlook

Geographically, the global ultrasound skin cleaners market is segmented into North America, Latin America, Europe, Asia-Pacific excluding Japan (APEJ), CSI & Russia, Japan and the Middle East and Africa (MEA). North America is expected to be the dominant market in the global ultrasound skin cleaners market owing to the growing awareness amongst general public, flourishing entertainment industry and increasing expenditure on maintaining personal aesthetics. The ultrasound skin cleaners market in Asia Pacific excluding Japan is expected to grow at a significant CAGR due to increasing exposure to skin care products and the urbanizing landscape.

Ultrasound Skin Cleaners Market: Key Players

The global market for neuro ablation market is highly fragmented. Examples of some of the key players operating in the global ultrasound skin cleaners market Kostech, CosBeauty, TEI Spa Beauty, Trophy Skin, Rio Beauty, Top Beauty Buy, Anself SA, MiroPure, Shenzhen Ckeyin Technology Co Ltd, and Artstor, among others.

The report covers exhaustive analysis on:

Market Segments
Market Dynamics
Market Size
Supply & Demand
Current Trends/Issues/Challenges
Competition & Companies involved
Technology
Value Chain
Regional analysis includes

For more information on this report, please visit:https://www.factmr.com/report/2286/ultrasound-skin-cleaners-market

About Fact.MR

For more information on this press release visit: http://www.sbwire.com/press-releases/ultrasound-skin-cleaners-market-value-chain-and-forecast-2018-to-2028-1111284.htm

Media Relations Contact

Sudip Shaha
Head of Marketing
Fact.MR
Telephone: 353-1-6111-593
Email: Click to Email Sudip Shaha
Web: https://www.factmr.com

Fact.MR has announced the addition of the “Non-invasive Ventilator Market Forecast, Trend Analysis & Competition Tracking - Global Market Insights 2018 to 2028"report to their offering.

Rockville, MD -- (SBWIRE) -- 12/26/2018 -- Non-invasive Ventilator Market: Introduction

A ventilator is a life-supporting system that is used to inhale oxygen and exhale carbon dioxide from the body. It helps patients breathe easier who are suffering from breathing difficulty. A ventilator is also used during anesthesia, as anesthesia can disrupt the normal breathing functionality, and the ventilator ensures that the normal breathing process is carried out efficiently during surgery. A non-invasive ventilator is used as an airway support, administered through a face mask instead of an endotracheal tube. A non-invasive ventilator supports the patient in breathing without the need for tracheotomy. Non-invasive ventilators are gaining traction nowadays, as there is increasing preference for non-invasive ventilation over invasive ventilation. A non-invasive ventilator supports the patient by delivering the right inspiratory and expiratory pressure to meet the individual's ventilator demands. A non-invasive ventilator is used more frequently and treats a wider range of conditions. Patients with chronic obstructive pulmonary disease (CPOD) are mainly treated with these non-invasive ventilators in intensive care units. Other than COPD, conditions such as pneumonia, acute lung injury, asthma, acute respiratory distress syndrome, neuromuscular disease, chest wall disorder, and obesity hypoventilation syndrome are treated with non-invasive ventilators. A non-invasive ventilator is also useful in a homecare setting for the treatment of sleep-related disorders such as sleep apnea.

Get Free Exclusive Sample Copy of This Report @ https://www.factmr.com/connectus/sample?flag=S&rep_id=2290

Non-invasive Ventilator Market: Drivers and Restraints

The growing prevalence of respiratory disorders is expected to be a major factor driving the growth of the non-invasive ventilator market over the forecast period. According to WHO, around 65 million people have moderate to serve chronic obstructive pulmonary disease (CPOD), globally. Various technological advancements in ventilation devices with operating efficiency, and the increasing geriatric population are also impelling the growth of the non-invasive ventilator market. Risk factors such as obesity and diabetes; unhealthy lifestyles such as alcohol consumption and smoking; and irregular sleep patterns that develop into respiratory problems are expected to drive the market of non-invasive ventilators in the near future. The cumulative demand for new technology devices among surgeons is another major factor expected to drive the non-invasive ventilator market. Moreover, the benefits of non-invasive ventilators over invasive ventilators are expected to spur the demand for non-invasive ventilators over the forecast period. However, the high cost of these non-invasive ventilators is expected to hamper the growth of the non-invasive ventilator market. Moreover, the risk of not receiving sufficient ventilation due to an incorrect set-up is expected to restrain the growth of the non-invasive ventilator market.

Non-invasive Ventilator Market: Segmentation

Tentatively, the global non-invasive ventilator market can be segmented on the basis of product type, end user, and geography.

Based on product type, the global non-invasive ventilator market is segmented as:

Electric
Pneumatic
Elecro-Pneumatic
Based on end user, the global non-invasive ventilator market is segmented as:

Hospitals
Specialty Clinics
Home Care Settings
Ambulatory Surgical Centers
Non-invasive Ventilator Market: Overview

The global market for non-invasive ventilators is expected to witness moderate growth over the forecast period. The electric non-invasive ventilators segment is expected grow at the highest CAGR over the forecast period in the non-invasive ventilator market. The hospitals end user segment is expected to contribute a high share in the global non-invasive ventilator market. Nowadays, non-invasive ventilators are in the high demand among healthcare professionals and patients due to their many benefits.

Request Brochure of this Report @ https://www.factmr.com/connectus/sample?flag=B&rep_id=2290

Non-invasive Ventilator Market: Regional Outlook

Geographically, the global non-invasive ventilator market is segmented into America, Latin America, Europe, CIS & Russia, Asia Pacific excluding Japan (APEJ), Japan, and the Middle East and Africa (MEA). North America is expected to be a dominant market in the global non-invasive ventilator market, due to the rise in the prevalence of respiratory diseases in the United States. A large number of technology solution providers exist in the market in this region. Europe is expected to have the second-largest share in the global non-invasive ventilator market throughout the forecast period, due to the huge adoption of new technologies among healthcare professionals. The non-invasive ventilator market in Asia Pacific excluding Japan is expected to grow at a significant CAGR, owing to factors such as rising standards of living, lifestyle changes, rise in awareness levels, and focus on healthcare expenditure. Japan is expected to represent a significant share in the global non-invasive ventilator market, due to strong reimbursement policies and the increasing aging population.

Non-invasive Ventilator Market: Key Players

Examples of some of the key players operating in the global non-invasive ventilator market are ResMed Inc., Teleflex Incorporated, Hamilton Bonaduz AG, HEYER Medical AG, Respironics, Inc., Airon Corporation, Fisher & Paykel Healthcare, Magnamed, medin Medical Innovations GmbH, Mindray Medical International Limited, O-Two Medical Technologies Inc., Phoenix Medical Systems Pvt. Ltd., Smiths Medical, Inc., WILAmed GmbH, and others.

The report covers exhaustive analysis on:

Market Segments
Market Dynamics
Market Size
Supply & Demand
Current Trends/Issues/Challenges
Competition & Companies Involved
Technology
Value Chain
Regional analysis includes:

For more information on this report, please visit:https://www.factmr.com/report/2290/non-invasive-ventilator-market

For more information on this press release visit: http://www.sbwire.com/press-releases/non-invasive-ventilator-market-analysis-trends-forecast-2018-to-2028-1111285.htm

Media Relations Contact

Sudip Shaha
Head of Marketing
Fact.MR
Telephone: 353-1-6111-593
Email: Click to Email Sudip Shaha
Web: https://www.factmr.com

Fact.MR has announced the addition of the “Conjugated Estrogen Market Forecast, Trend Analysis & Competition Tracking - Global Market Insights 2018 to 2028"report to their offering.

Rockville, MD -- (SBWIRE) -- 12/26/2018 -- Conjugated estrogen is an active pharmaceutical ingredient that contains a mixture of steroidal and non-steroidal components that are obtained from pregnant mares' urine. Conjugated estrogen is used as an external source and is prescribed as a replacement of female natural hormones. Estrogen has many well-known effects on the tissues of the body. It causes the growth of the inner lining of uterus, secretion of cervix, development & growth of female sexual organs and maintains the sexual characteristics of females, such as hair growth of underarm and pubic area and countering of body and bone. Menopause is diagnosed when a woman has not had menses for one year. Due to the low production of estrogen in the body, about 85% of women have symptoms such as hot flushes, bone loss, vaginal dryness and shrinkage of tissues. For these symptoms, menopause hormone treatment therapy is the most effective treatment. Conjugated estrogen helps menopausal women treat symptoms such as shrinkage of vaginal tissue, vaginal dryness, hot flashes, bone loss and painful intercourse. However, there are many side effects of conjugated estrogen such as breast swelling, abdominal pain, vaginal bleeding, nausea and mood swings. Patients with heart & kidney diseases should be careful while taking conjugated estrogen as it cause retention of salt & water in the body. Also, a high dose of conjugated estrogen can cause clotting of blood in legs and lungs. Hence, smokers have a high risk of clots and are recommended to quit smoking if they are prescribed conjugated estrogen. Before taking conjugated estrogen, its side effects, dosage, drug interactions, risks and storage should be reviewed properly.

Conjugated Estrogen Market: Drivers and Restraints

Menopause is a natural and normal process in women, which occurs due to aging and lowers the function of ovaries and lowers the levels of estrogen and other hormones in the body. The growing prevalence of the female geriatric population and women with menopause is the major factor driving the growth of the conjugated estrogens market over the forecast period. However, limited awareness and negligence about women healthcare services in developing nations and related side effects among women due to menopause hormone treatment therapy are restraining the revenue growth of the global conjugated estrogen market.

Get Free Exclusive Sample Copy of This Report @ https://www.factmr.com/connectus/sample?flag=S&rep_id=2289

Conjugated Estrogen Market: Segmentation

The global conjugated estrogen market can be segmented on the basis of form, route of administration, end user and geography.

Based on form, the global conjugated estrogen market has been segmented as:

Tablets
Creams
Powder
Vials
Based on route of administration, the global conjugated estrogen market has been segmented as:

Oral
Topical
Injection
Based on end user, the global conjugated estrogen market has been segmented as:

Hospitals
Obstetrics & Gynecology Clinics
Others
Based on geography, the global conjugated estrogen market has been segmented as:

North America
Latin America
Europe
Asia-Pacific excluding Japan (APEJ)
Japan
Middle East & Africa (MEA)
Conjugated Estrogen Market: Overview

The global market for conjugated estrogen is expected to grow at a high rate over the forecast period. Rising population of ageing women with menopause and the rising demand for treatment-related menopause are driving the growth of the conjugated estrogen market. Women with menopause are at a high risk of cardiovascular disease and osteoporosis due to the low production of estrogen in the body. Decreased production of estrogen causes loss of bone density, which in turn causes osteoporosis and fractures in women. Conjugated estrogen is well-known as an external source and is prescribed as a replacement for female natural hormones. It can be helpful to maintain and balance women health and deal with the symptoms caused by menopause. However, conjugated estrogen is not prescribed to women who have undergone surgical removal of the uterus as estrogen promote abnormal thickening of the lining of the uterus, which can increase the risk of endometrial cancer. But the combination of progestin with estrogen can prevent endometrial cancer. Also, there is a high risk of memory loss and disturbance of thinking process among women over age 65 treated with conjugated estrogen. These factors can retrain the growth of the conjugated estrogen market.

Request Brochure of this Report @ https://www.factmr.com/connectus/sample?flag=B&rep_id=2289

Conjugated Estrogen Market: Regional Outlook

On the basis of geography, the global conjugated estrogen market has been segmented into viz. North America, Latin America, Europe, Asia-Pacific excluding Japan (APEJ), Japan and the Middle East & Africa (MEA). North America is expected to be the dominant market in the global conjugated estrogen market due to growing prevalence of the geriatric female population with menopause, initiatives towards increasing female health awareness and health coverage. Conjugated estrogen is specifically approved in the United States and Canada for menopause-related problems. Europe is expected to register the second largest share in the global conjugated estrogen market throughout the forecast period, owing to the increasing awareness regarding female healthcare. The conjugated estrogen market in Asia Pacific excluding Japan is expected to grow at a high CAGR due to large population growth and increasing aging population of women and large presence of local players.

Conjugated Estrogen Market: Market Participants

Some of the key players in the global conjugated estrogen market include Pfizer Inc., Teva Pharmaceuticals USA, Inc., Xi'an sgonek biological Technology Co., Ltd., Teva Branded Pharm and others.

The report covers exhaustive analysis on:

Market Segments
Market Dynamics
Market Size
Supply & Demand
Current Trends/Issues/Challenges
Competition & Companies involved
Technology
Value Chain
Regional analysis includes

North America (U.S., Canada)
Latin America (Mexico, Brazil)
Western Europe (Germany, Italy, U.K., Spain, France, Nordic countries, BENELUX)
Eastern Europe (Russia, Poland, Rest of Eastern Europe)
Asia Pacific Excluding Japan (China, India, Australia & New Zealand)
Japan
Middle East and Africa (GCC, S. Africa, Rest Of MEA)
Report Highlights:

For more information on this report, please visit:https://www.factmr.com/report/2289/conjugated-estrogen-market

For more information on this press release visit: http://www.sbwire.com/press-releases/conjugated-estrogen-market-forecast-report-on-market-2018-to-2028-1111287.htm

Media Relations Contact

Sudip Shaha
Head of Marketing
Fact.MR
Telephone: 353-1-6111-593
Email: Click to Email Sudip Shaha
Web: https://www.factmr.com

Fact.MR has announced the addition of the “MRI Guided Drug Delivery Market Forecast, Trend Analysis & Competition Tracking - Global Market Insights 2018 to 2028"report to their offering.

Rockville, MD -- (SBWIRE) -- 12/26/2018 -- MRI Guided Drug Delivery Market: Introduction

MRI guided drug delivery or magnetic resonance guided drug delivery is a part of an advanced drug delivery system that helps transport a therapeutic agent from the site of administration to the targeted area. The MRI guided drug delivery technique not only helps reduce non-target distribution of the drug but also increases drug concentration in the targeted area. The main advantage of MRI guided drug delivery is that the release of the therapeutic agent at a specific site can be quantified and also visualized by real-time settings. The MRI guided drug delivery procedure decreases unwanted effects of the therapeutic agent on healthy tissues, and hence, this decreases side effects like bleeding, edema, etc., and reduces the need for emergency treatment. From a clinical point of view, the MRI guided drug delivery technique is a less painful, as a non-invasive or minimally invasive approach is used. The MRI guided delivery system offers increased dwell time and slow uptake of the therapeutic agent, which enhances the efficacy of the treatment. There are mainly two types of products available in the market that follow MRI guided drug delivery techniques. First is, high intensity focused ultrasound (HIFU). It is an emerging non-invasive method of MRI guided drug delivery. HIFU uses ultrasonic radiation to heat the tumor, which causes necrosis, hence, temperature-sensitive carrier molecules, such as liposomes, micelles, or polymers release the drug while passing through it. The other MRI guided drug delivery technique uses MRI imaging to map the course of drug movement, and also to visualize the concentration in the targeted area. The MRI guided delivery system uses multifunctional super-paramagnetic iron oxide (SPIO)-based nanoparticles as a nano-system candidate for the diagnosis and treatment of cancer.

Get Free Exclusive Sample Copy of This Report @ https://www.factmr.com/connectus/sample?flag=S&rep_id=2291

MRI Guided Drug Delivery Market: Drivers and Restraints

The growing demand for MRI guided drug delivery is because of its non-invasive or minimally invasive approach, which causes less side effects and less pain as compared to other alternatives. Other factors expected to drive the MRI guided drug delivery market include advancements in medical technologies, growing prevalence of cancer and other chronic diseases, increase in diagnostic rates among the population with chronic diseases, adoption in therapeutic areas for treatment purposes such as oncology (unresectable tumors, bone cancer, intra or extracrenial neoplasms, prostate cancer, breast cancer), woman's health (uterine fibroids), neurological disorders, and cosmetic medicine, among others. However, MRI guided drug delivery is not a cost-effective method, which restricts its acceptance by patients. Less awareness towards the technique is another factor limiting the growth of the global MRI guided drug delivery market.

MRI Guided Drug Delivery Market: Segmentation

Tentatively, the global MRI guided drug delivery market can be segmented on the basis of product type, application, indication, end user, and geography.

Based on product type, the global MRI guided drug delivery market is segmented as:

MRI Guided Drug Delivery Combined with Ultrasound Radiation (Non-invasive)
MRI Guided Drug Delivery without Ultrasound Radiation (Minimally Invasive)
Based on application, the global MRI guided drug delivery market is segmented as:

Diagnostic
Therapeutic
Based on indication, the global MRI guided drug delivery market is segmented as:

Cancer
Neurological Disorders
Uterine Fibroids
Others (e.g. Cosmetic Medicine)
Based on end user, the global MRI guided drug delivery market is segmented as:

Hospitals
Diagnostic Centers
MRI Guided Drug Delivery Market: Overview

The global market for MRI guided drug delivery is expected to generate significant revenue with a huge growth over the forecast period, due to the high demand for painless, non-invasive methods for the treatment of serious indications. Among the two product types of MRI guided drug delivery systems, non-invasive systems are expected to experience high demand across all end users. The hospitals end user segment is expected to contribute the highest share in the global MRI guided drug delivery market, due to requirement of highly developed infrastructure for such systems. Among various indications of MRI guided drug delivery systems, the cancer segment is expected to gain traction over the forecast period, primarily due to growing prevalence of cancer, and the availability of reimbursements. Some of the popular brands of MRI guided drug delivery systems include TULSA-PRO (Profound Medical Corp), NeuroBlate (Monteris), MRGFUS (Insightec Ltd.) etc.

Request Brochure of this Report @ https://www.factmr.com/connectus/sample?flag=B&rep_id=2291

MRI Guided Drug Delivery Market: Regional Outlook

Geographically, the global MRI guided drug delivery market is segmented into North America, Latin America, Europe, CIS & Russia, Asia Pacific Excluding Japan, Japan, and the Middle East & Africa. North America's MRI guided drug delivery market is expected to remain dominant in the global MRI guided drug delivery market, on the account of growing research applications of MRI guided drug delivery along with increased set up of advanced diagnostic laboratories in the region. Europe's MRI guided drug delivery market is expected to contribute the second-largest revenue share in the global MRI guided drug delivery market throughout the forecast period, owing to the increased presence of distributors and suppliers for MRI guided drug delivery devices across the region. However, the fastest growth is expected from Asia Pacific, mainly from countries such as Japan and China, because they are attracting manufacturers with a lots of possibilities to explore their business in the MRI guided drug delivery sector.

MRI Guided Drug Delivery Market: Key Players

The global MRI guided drug delivery market is highly consolidated with a small number of global players operating in it. Some of the players identified in the global MRI guided drug delivery market are Chongqing Haifu Medical Technology Co., Ltd., Monteris, Profound Medical Corp, Insightec Ltd., Alpinion Medical Systems Co., Ltd., Episonica, and others.

The report covers exhaustive analysis on:

Market Segments
Market Dynamics
Market Size
Supply & Demand
Current Trends/Issues/Challenges
Competition & Companies Involved
Technology
Value Chain
Regional analysis includes:

North America (U.S., Canada)
Latin America (Mexico, Brazil, Argentina, Chile, Peru, and Rest of Latin America)
Europe [EU -4 (Germany, France, Italy, Spain), BENELUX (Belgium, Netherlands, Luxemburg), NORDIC (Norway, Denmark, Iceland, Sweden), Eastern Europe (Poland, Ukraine, Czech Rep., etc.), Rest of Europe
CIS & Russia
Japan
APEJ (Greater China, India, S. Korea, ASEAN Countries and Rest of APEJ)
Middle East & Africa (GCC Countries, Turkey, Iran, Israel, South Africa, Rest of MEA)
Report Highlights:

For more information on this report, please visit:https://www.factmr.com/report/2291/mri-guided-drug-delivery-market

About Fact.MR

For more information on this press release visit: http://www.sbwire.com/press-releases/mri-guided-drug-delivery-market-poised-for-steady-growth-in-the-future-2018-to-2028-1111288.htm

Media Relations Contact

Sudip Shaha
Head of Marketing
Fact.MR
Telephone: 353-1-6111-593
Email: Click to Email Sudip Shaha
Web: https://www.factmr.com

Fact.MR has announced the addition of the “Biologic Injectors Market Forecast, Trend Analysis & Competition Tracking - Global Market Insights 2018 to 2028"report to their offering.

Rockville, MD -- (SBWIRE) -- 12/26/2018 -- Biologic injectors are the injecting devices used to deliver drugs and other substances for biological purposes. Biological products such as drugs, growth hormones, antibodies and other complex biological molecules are administered into the body of an organism through biologic injectors. Biologic injectors are basically used for the treatment of various diseases.

Biologic injectors offer different methods of administration such as simple piston, gas, jet and others. They can also be used for the storage or handling of biological molecules. Accurate dosing is one the most important advantages offered by biologic injectors. Thus, the risk of overdose of a drug is significantly reduced with the use of biologic injectors, which is considered as a major advantage of biologics injectors. Biologic injectors can be used for the delivery of general drug or any drug of a specific product line. They can be used for the administration of single doses or multiple doses and the dosage of the drug can be adjusted by the user.

Biologic Injectors Market: Drivers and Restraints

The increasing demand for drug delivery is expected to be the major factor driving the growth of the biologic injectors market over the forecast period. The introduction of disposable and reusable biologic injectors is expected to drive the growth of the biologic injectors market. The incidences of cancer, brain diseases and heart diseases are increasing, which is significantly driving the growth of the biologic injectors market .This in turn is expected to increase the revenue share of the biologic injectors market. Biologic injectors are associated with the accurate dosing of drugs and prevention of sharp injuries.

On the other hand, the difficulties associated with the delivery of highly viscous drugs can restrain the biologic injectors market .Other factors such as risk of infection at the site of administration may also hinder the growth of the biologic injectors market.

Get Free Exclusive Sample Copy of This Report @ https://www.factmr.com/connectus/sample?flag=S&rep_id=2288

Biologic Injectors Market: Segmentation

Tentatively, the global biologic injectors market can be segmented on the basis of treatment, indication, distribution channel and geography.

Based on application, the global biologic injectors market has been segmented as:

Oncology
Cardiology
Autoimmune
Pain management
Others
Based on distribution channel, the global biologic injectors market has been segmented as:

Hospital Pharmacies
Retail Pharmacies
Drug Stores
Online Pharmacies
Others
Biologic Injectors Market: Overview

The global market for biologic injectors is expected to witness moderate growth over the forecast period. Biologic injectors find a vast range of applications such as oncology, cardiology, autoimmune disorders and many others. Based on distribution channel, the biologic injectors market has been segmented into hospitals, pharmacies and various other drug stores. Drug delivery is one of the main applications where biologic injectors play an important role.

Request Brochure of this Report @ https://www.factmr.com/connectus/sample?flag=B&rep_id=2288

Biologic Injectors Market: Regional Outlook

On the basis of geography, the global biologic injectors market has been segmented into viz. North America, Latin America, Europe, Asia-Pacific excluding Japan (APEJ), Japan and the Middle East and Africa (MEA). North America is expected to be the dominant region in the global biologic injectors market, owing to advancements in healthcare technologies in the region. Europe is expected to hold the second large share in the global biologic injectors market throughout the forecast period.

Biologic Injectors Market: Market Participants

The global market for biologic injectors is highly fragmented. Examples of some of the key players operating in the global biologic injectors market are Roche, Abbott, Schott, Nipro, Ompi, Becton and Dickinson & Co., Bayer AG, Pfizer, Inc., Bristol-Myer Squibb, Novartis International AG, Novartis AG and others.

The report covers exhaustive analysis on:

Market Segments
Market Dynamics
Market Size
Supply & Demand
Current Trends/Issues/Challenges
Competition & Companies involved
Technology
Value Chain
Regional analysis includes

North America (U.S., Canada)
Latin America ( Brazil, Mexico, Argentina, Chile, Peru, Rest of LATAM)
Europe (Germany, Italy, U.K., Spain, France, Russia, Belgium, Netherlands, Luxemburg, Norway, Denmark, Iceland, Sweden, Poland, Ukraine, Czech Rep, Rest of Europe)
Asia Pacific Excluding Japan (India, Australia & New Zealand, Greater China, S. Korea, ASEAN Countries, Rest of APEJ)
Japan
CIS & Russia
Middle East and Africa (GCC, Turkey, Iran, Israel, South Africa, Rest of MEA)
Report Highlights:

For more information on this report, please visit:https://www.factmr.com/report/2288/biologic-injectors-market

About Fact.MR

For more information on this press release visit: http://www.sbwire.com/press-releases/biologic-injectors-market-to-increase-at-steady-growth-rate-2018-to-2028-1111286.htm

Media Relations Contact

Sudip Shaha
Head of Marketing
Fact.MR
Telephone: 353-1-6111-593
Email: Click to Email Sudip Shaha
Web: https://www.factmr.com

Fact.MR has announced the addition of the “Brain Tissue Oxygen Monitoring Systems Market Forecast, Trend Analysis & Competition Tracking - Global Market Insights 2018 to 2028"report to their offering.

Rockville, MD -- (SBWIRE) -- 12/26/2018 -- The brain tissue oxygen monitoring systems are employed for the continuous monitoring of oxygen partial pressure in the brain, thus providing early warning of hypoxic events, thereby allowing timely intervention to restore oxygen delivery. Brain tissue oxygen monitoring systems are used for patients suffering from traumatic brain injury and cerebral vascular events such as strokes & others.

Brain Tissue Oxygen Monitoring Systems Market: Drivers and Restraints

The rising incidence and cases of brain diseases and disorders such as traumatic brain injury (TBI), strokes and others, coupled with the high demand for the brain tissue oxygen monitoring systems are the prime drivers of the brain tissue oxygen monitoring system market. According to the Centers for Disease Control and Prevention (CDC), about 2.8 million TBI-related hospitalisations and deaths occurred in the U.S. in 2016, which amounted to 50,000 deaths. The CDC data also reveals an astonishing increase in TBI-related hospitalisations, which grew by 47% during a span of six years from 2010 to 2016.

Get Free Exclusive Sample Copy of This Report @ https://www.factmr.com/connectus/sample?flag=S&rep_id=2292

The measurement of oxygen partial pressure in the brain is critical to the prognosis and treatment of patients as there is no definitive curative treatment for brain trauma, which is the clinical driver of the brain tissue oxygen monitoring systems market. Brain oxygen is a key parameter of mortality in traumatic brain injury as even small periods of hypoxia and hypotension can significantly boost mortality. Thus the low elasticity of demand for brain tissue oxygen monitoring systems is expected to propel the brain tissue oxygen monitoring systems market to attractive growth.

Drawbacks of traditional methods of measuring brain tissue oxygen are another driver of the brain tissue oxygen monitoring systems market. The usage of traditional methods of measuring brain tissue oxygen, such as positron emission tomography and Computed Tomography (CT), are limited for the continuous measurement of brain oxygenation. Peripheral methods for brain tissue oxygen measurement, such as intracranial pressure and cerebral perfusion pressure, are not reliable as they are sensitive to peripheral tissue oxygen extraction.

Growth in risk factors represents an attractive market opportunity for the brain tissue oxygen monitoring systems market. The growth in demand generated by increase in risk factors, such as growing sports culture, increase in the number of active population such as young children, growing geriatric population, lack of safety and increase in the number of vehicles is expected to drive large revenues for the brain tissue oxygen monitoring systems market players. According to CDC, falls are the leading cause of TBI and account for 47% of all TBI-related hospitalizations and deaths in the U.S., disproportionately affecting the youngest and oldest age groups. The CDC states that the rates of recreation-related TBI have more than doubled among children aged 19 years and below. Of all TBI-related hospitalizations and deaths among adults aged 65 and above, almost 79% were caused by falls. Motor vehicle crashes was the third leading cause of all TBI-related hospitalizations and deaths among all age groups, and accounted for a 14% share.

Request Brochure of this Report @ https://www.factmr.com/connectus/sample?flag=B&rep_id=2292

Advancements in technology, such as the development of advanced algorithms, data storage capabilities, interactive touch-screen interfaces for immediate access, compact, lightweight ergonomic design, improvements in battery life, built-in alarms and others, are also among factors driving the brain tissue oxygen monitoring systems market.

However, the high cost of installation and maintenance of brain tissue monitoring systems, the lower penetration of brain trauma centres & multispecialty hospitals in developing regions and lack of awareness are among factors hampering the growth of the brain tissue oxygen monitoring systems market.

Brain Tissue Oxygen Monitoring Systems Market: Segmentation

The global brain tissue oxygen monitoring systems market is segmented based on mechanism, distribution channel and region.

Based on mechanism, the global brain tissue oxygen monitoring systems market is segmented into:

Clark electrode technology
Fluorescence and Fiberoptic luminescence quenching technology
Based on portability, the global brain tissue oxygen monitoring systems market is segmented into:

Non-portable
Portable
Based on end user, the global brain tissue oxygen monitoring systems market is segmented into:

Hospitals
Neurology clinics
Ambulatory Care Centres
Brain Tissue Oxygen Monitoring Systems Market: Overview

The global brain tissue oxygen monitoring systems market is a highly consolidated characterised by the availability of technologically advanced brain tissue monitoring systems, but low volumes of sale. This has resulted in the premium pricing of products, owing to which only few players dominate the brain tissue oxygen monitoring systems market.

Vendors operating in the brain tissue oxygen monitoring systems market are engaged in new product developments, as the most popular strategy. Technical support and customised solutions are the recent market demands and trends playing a crucial role in the brain tissue oxygen monitoring systems market. The introduction of technologically advanced products is expected to present a larger value proposition as compared to cost in the brain tissue oxygen monitoring systems market.

Brain Tissue Oxygen Monitoring Systems Market: Regional Outlook

By region, the global brain tissue oxygen monitoring systems market is classified into North America, Latin America, Western Europe, Eastern Europe, Asia-Pacific, Japan and Middle East & Africa. North America dominated by the U.S. accounts for the largest share of the global brain tissue oxygen monitoring systems market owing to the excellent healthcare infrastructure, the local presence of large players and the higher demand for neurosurgery.

North America is followed by Europe, which is expected to be led by Germany, France and the U.K. The large healthcare infrastructure of Europe is a significant driver of the Europe brain tissue oxygen monitoring systems market.

The brain tissue oxygen monitoring systems market is expected to gain significant traction in the Asia Pacific and the Middle East & Africa regions. China and India are expected to drive a large market share owing to economic development, large population and advancements in healthcare in the Asia Pacific brain tissue oxygen monitoring systems market.

The Middle East and Africa brain tissue oxygen monitoring systems market is expected to be dominated by the wealthy gulf economies of Saudi Arabia, Kuwait, UAE and Qatar. However, the poor income of African economies, coupled with poor social conditions, are hampering the brain tissue oxygen monitoring systems market.

Brain Tissue Oxygen Monitoring Systems Market: Key Players

Some of the major vendors operating in the global brain tissue oxygen monitoring systems market are Integra LifeSciences Corporation; Hamamatsu Photonics K.K.; Medtronic; Scintica Instrumentation, Inc.; CARDION s r.o.; Oxford Optronix Ltd., RAUMEDIC AG among others.

The global brain tissue oxygen monitoring systems market report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

The brain tissue oxygen monitoring systems market report covers exhaustive analysis on:

Market Segments
Market Dynamics
Market Size
Supply & Demand
Current Trends/Issues/Challenges
Competition & Companies involved
Technology
Value Chain
Regional analysis includes

North America (U.S., Canada)
Latin America (Brazil, Mexico, Argentina, Chile, Peru, Rest of LATAM)
EU – (Germany, France, Italy, Spain), UK, BENELUX (Belgium, Netherlands, Luxemburg), NORDIC (Norway, Denmark, Iceland, Sweden), Eastern Europe (Poland, Ukraine, Czech Rep. etc.), Rest of Europe
CIS & Russia
Japan
Asia Pacific Excluding Japan (Greater China, India, S. Korea, ASEAN Countries, Rest of APEJ)
Middle East and Africa (GCC Countries, Turkey, Iran, Israel, South Africa , Rest of MEA)
Report Highlights: